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The modification of proteins and the further decoration of them using reactive chromophores 
represent a recent topic of scientific interest. In this thesis, novel approaches toward 
site-directed protein modifications will be explored via either biology or chemistry means. In 
conjunction with those novel protein modification approaches, reactive rhodamine B dyes 
were prepared as useful chromophores to decorate those functionalized proteins and peptide. 
 
First of all, a biology method termed selective pressure incorporation (SPI) was developed to 
incorporate non-canonical amino acid (NCAA) into proteins in a site-directed fashion as 
exemplified by the incorporation of azidohomoalanine (AHA) into ribonuclease A (RNase A) 
in this thesis. AHA which is an analogue of methionine was synthesized with a considerably 
enhanced yield compared to recently reported protocols. This NCAA was efficiently 
incorporated into the protein RNase A via SPI, thus giving rise to a site-directed bi-azido 
functionalized RNase variant with two surface AHA located at AHA1 and AHA41 
respectively. 
 
Two chemistry approaches toward site-directed protein modifications were also established 
that target cysteine (Cys) and lysine (Lys) respectively. The first cysteine-targeting approach 
requires the protein substrates to bare a single accessible cysteine residue on its surface, such 
as serum albumin proteins, antibody monomers and etc.. Compared to this method, the second 
chemistry approach which addresses lysine residue displays a wider application scope as 
 ix 
lysine typically exists on most protein surfaces. The solvent accessibility of each lysine 
residue as well as the interaction between lysine and other residues in close vicinity play an 
important role to achieve the site-directionality. The success of this work was demonstrated 
by the mono-biotinlylation of RNase A, lysozyme C and somatostatin (SST) using a novel 
bioconjugation reagent—biotin-PEG-NHS (49).  
 
The last part of this thesis is dedicated to the preparation of functionalized rhodamine B dyes 
as reactive chromophore to label functional protein/peptides, such as azido-antibody and SST. 
This is a one step approach toward functionalized rhodamine B dyes via Steglich 
esterification. Compared to the previously reported protocol, this route is more practical, 
concise and avoids the usage of highly reactive reagents. Aside from rhodamine B ethyl ester, 
three reactive rhodamine B derivatives were prepared. They are propargyl rhodamine B ester 
for targeting azido group, azidoethyl rhodamine B ester for targeting ethynyl group and 
monosulfone-OH rhodamine B ester for targeting accessible disulfide bonds. Finally, their 
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Chapter 1. INTRODUCTION 
 
Modifications of proteins in a site-directed way and labeling proteins with chromophore(s) at 
distinct site(s) gained enormous interest from both biologists and chemists due to their 
attractive applications.[1~11] The dynamics of a protein can be investigated via fluorescence 
correlation spectroscopy (FCS) after attachment of a fluorescent chromophore.[1,2,3] If there 
are two photo-stable fluorophores located at two distinct positions on a protein within a 
proper range, conformational changes of a protein in solution such as the mechanism of 
proteolysis of an enzyme could be studied e.g. via fluorescence resonance energy transfer 
(FRET).[4,5,6] Conjugation of poly(ethylene oxide) chains (PEGylation) onto therapeutic 
proteins alters their pharmacokinetic profile and increases their half-life time in the body thus 
improving their therapeutic effects.[7,8,9,10] Furthermore, decoration of proteins with polymer 
chains in a defined manner could generate novel protein biohybrids with tailored properties 
different from the native ones.[11] Therefore, developing novel protein modification strategies 
that allow site-directed modification reactions on a protein surface and synthesis of novel 
fluorophores are highly appealing. 
 
In the following, major published approaches for protein modification will be reviewed. 
Firstly, the biological method, selective pressure incorporation (SPI), which utilizes reactive 
non-canonical amino acids (NCAA) will be briefly introduced. Thereafter, different chemistry 
approaches for protein modifications will be discussed as well. In conjunction with protein 
modification, prominent functionalization strategies of the chromophore rhodamine B as 
useful protein decoration reagents will be summarized. Unfortunately, all these methods 
suffer from different limitations and the challenges behind them will be discussed as well. 
This thesis is dedicated in providing some feasible solutions to each problem and they will be 
discussed in detail in the Results and Discussion chapter.  
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1.1. Protein Modification via Selective Pressure Incorporation (SPI) 
1.1.1. BACKGROUND 
Living cells utilize 21 naturally occurring amino acids (aside from a few exceptions) as 
building blocks to produce a large variety of proteins. This process includes two major steps 
termed transcription and translation. Usually, the cell’s own set of translational machineries 
work cooperatively to ensure the two processes proceed correctly. 
 
However, it has been found that in living cells, the translational machineries can be 
manipulated in order to accept synthetic amino acids that are not produced by living 
organisms.[18] This discovery opened one possibility: certain cells can recognize exogenous 
natural amino acids analogues based on which novel proteins are produced that do not exist in 
nature. This new research branch was explored by several groups and significant progress was 
made during the past few years. The first approach, nonsense codon suppression, was 
developed by Schultz et al.[19,20,21,22] using a unique codon and a corresponding tRNA: 
aminoacyl-tRNA-synthetase pair. Via this method, NCAA can be inserted into a protein at a 
distinct position(s) either in prokaryotic or eukaryotic cells. However, this technique is 
complicated and technically demanding. Another strategy termed selective pressure 
incorporation (SPI) was first developed by Tirrel et al.[23,24,25,26] This strategy makes use of 
auxotrophic E. coli strains that are not able to produce a certain amino acid and which can 
only grow if the nutrient media contains this amino acid. In the case that a very close 
analogue of the natural amino acid is added, and the cell cannot distinguish between the 
natural amino acid and the structurally close analogues during the translation process, the 
NCAA is inserted into the protein codon. As a result, a recombinant protein containing NCAA 
is produced. This biological method is generally considered less challenging as compared to 
nonsense codon suppression. This is mainly because this approach does not require the 
development of a new transfer-RNA: aminoacyl-tRNA-synthetase pair. 
 
1.1.2. AN INTRODUCTION TO SPI 
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The SPI process is briefly described in figure 1 using a methionine auxotrophic E. coli strain 
for AHA-protein expression as an example. First of all, an auxotrophic E. coli strain is applied 
which is unable to self-generate methionine for growing. Subsequently, an engineered 
plasmid that can express a certain protein of interest is introduced into E. coli cells. Then, the 
E. coli cells are fed with a medium containing AHA, a close analogue of the natural amino 
acid methionine which allows them to grow and insert AHA into the protein sequence instead 
of methionine. This process is called selective pressure incorporation of AHA. When the 
growth of E. coli ceases, the cell culture is subjected to cell lyses in order to release the 
expressed AHA-protein.  
 
Figure1. The general steps that are involved in the incorporation of a NCAA (e.g. AHA 
(2)) into a protein (e.g. RNase A) via SPI. 
 
1.1.3. TRANSLATIONALLY ACTIVE NCAAs IN SPI 
In the past, several NCAAs were incorporated into a few proteins by the SPI approach. Using 
methionine auxotrophic bacteria strains, propargylalanine (1)[23] and AHA (2)[24] were 
efficiently incorporated into several proteins. Those proteins are attractive since the presence 
of azido or ethynyl groups allows for subsequent click reactions. For instance, recombinant 
proteins bearing azido groups could be used for site-specific Staudinger ligation by reacting 
with appropriate triarylphosphine reagents.[25] In addition, 4-ethynylphenylalanine (4), 
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4-azidophenylalanine (5) and 4-iodophenylalanine (6) were found to replace phenylalanine 
when using phenylalanine auxotrophic bacteria strains.[27] Regardless of the diversity of 
NCAA, only a few recombinant proteins were successfully expressed by this approach such 
as AHA-CalB, AHA-RNase A.[28] and ketone-T4L lysozyme.[12] Some typical NCAA that 
have been successfully applied to protein expression and that are translationally active are 




























Figure2 a-b. Some typical translationally active NCAAs in SPI including: a. methionine 
analogues (propargylhomoglycine (1), AHA (2) and allylalanine (3)). b. phenylalanine 
analogues (4-ethynylpehynylalanine (4), 4-azidophenylalanine (4) and 
4-iodophenylalanine (6)). 
 
1.1.4. LIMITATIONS OF SPI 
Although SPI is an excellent technique for producing proteins modified in a site-directed 
fashion, it suffers from several limitations. The major limitation is that one NCAA would 
replace all its corresponding native residues during protein expression thus affording proteins 
with multiple reactive NCAAs. If mono-functionalization is a key concern, one way to 
circumvent this limitation is via the selection of a proper residue that is the only one exposed 
on the protein surface. This strategy has been applied to the expression of AHA-CalB etc. 
Since methionine is often a rare residue and is usually buried inside the protein scaffold, it is 
often selected for preparing mono-functionalized proteins[28]. As for lysozyme, only one 
methionine out of five is located on the surface. Incorporation of AHA afforded AHA-CalB 
with only one accessible AHA on its surface[27]. The structure of CalB and the distribution of 
methionine in CalB are shown in figure 3. In case methionine is not present on the protein 
Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
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surface, introduction of point mutation will be necessary.  
 
Figure3. The crystal structure of CalB where all methionine residues are indicated by 
red sticks except the one located on the surface highlighted by yellow spheres (PDB 
file: 1tca). 
 
1.1.5. SYNTHESIS of NCAAs 
The development of synthetic strategies in order to achieve NCAA in high yields represents a 
challenge for chemists mainly due to the structure diversity of various NCAAs. In order to 
achieve sufficient quantities of a protein of interest bearing NCAA, usually gram scale 
quantities of the respective NCAA is required. In the following, the most prominent ways to 
prepare reactive NCAAs are summarized. 
 
In order to introduce an azido group as present in AHA, there are two major routes that 
involve either diazotransfer or nucleophilic substitution reactions by an appropriate 
azide-reagent (Scheme 1). Triflic azide has been found to act as the initial successful diazo 
transfer reagent and has been mainly used until now and most of the recently reported 
synthetic routes to AHA still employ this reagent.[13,14,15] However, it also suffers from several 
severe limitations such as its highly explosive nature upon shaking, heating and concentrating, 
which hampers upscaling. In addition, triflic azide is toxic and decomposes quickly during 
storage. These drawbacks led to the development of the new diazotransfer 
reagent—imidazole-1-sulfonyl azide hydrochloride.[16] Compared to triflic azide, this 
compound is not explosive and can be stored for months without obvious loss of efficacy. In 
the second method, the NCAA precursor is treated with sodium azide. The two protocols are 
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Scheme1 a-b. The two major routes toward the preparation of azido-containing 
NCAAs are via either diazotransfer (a) or nucleophilic substitution using sodium azide 
(b). 
 
The Sonogashira coupling reaction represents a powerful approach to introduce ethynyl 
groups onto phenyl rings as demonstrated by the synthesis of 4-ethynylphenylalanine (4) 
(Scheme 2a).[17] Ethynyl-containing aliphatic amino acid can be prepared via Strecker 
synthesis using a ethynyl-containing precursor. For instance, after treatment with ammonium 
and sodium cyanide followed by hydrolysis, pent-4-ynal (7) is converted into 

























a. via Sonogashira coupling
b. via Strecker synthesis
 
Scheme2 a-b. Two routes toward the synthesis of ethynyl-containing NCAAs. [45] 
 
One important consideration of this synthesis scheme is related to the stereochemistry of the 
!-carbon of the NCAA. It has been demonstrated by experiments that racemic NCAA such as 
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(D,L)-AHA can be effectively incorporated into the amino acid codon so that no chiral 
separation of the racemic mixture is necessary. This is because the cell’s translational 
machinery can selectively recognize L-NCAA. The D-amino acid will not affect protein 
expression but will remain in the culture solution.  
 
1.2. Chemical Protein Modifications 
In the following, chemistry approaches toward protein functionalization will be highlighted. 
The most prominent reaction schemes to functionalize proteins targeting cysteine or lysine 
substituents since they either contain the reactive thiol group or the primary amino group. 
Unfortunately, these two approaches usually yield a heterogeneous protein mixture. For 
instance, PEGylation strategies to improve the properties of therapeutic proteins targeting 
lysine often afford products with a broad degree of modification. These limitations motivate 
the discovery of new site-directed protein modification strategies that only yield 
homogeneously functionalized proteins. In the following sections, recently developed protein 
modification strategies, both site-directed and none site-directed, will be reviewed.   
 
1.2.1. RESIDUE-SELECTIVE PROTEIN MODIFICATIONS 
Some protein modification strategies are able to address the side chains of certain amino acids 
on proteins without interfering with other amino acid residues. These modification methods 
are called residue-selective. In this subsection, the two most recently developed modification 
techniques are summarized.  
 
1.2.1.1. Tryptophan-Targeting Protein Modifications 
Tryptophan is considered an inert amino acid due to the absence of very reactive functional 
groups in its side chain. However, in the presence of transition metal catalysts, the aromatic 
ring system of the tryptophan side chain can be activated and participate in certain reactions. 
Previously, rhodium carbenoids were found to efficiently react with tryptophan residue[29] 
(Scheme 3). Compared to conventional lysine and cysteine modifications, targeting 
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tryptophan is attractive due to its low abundance on the protein surface. Therefore, this 
strategy generally shows a higher specificity toward achieving a defined product and further 
more, it only requires low protein concentrations at the micromolar level.    
 
Scheme3. Tryptophan-selective protein modification using rhodium carbenoids.[29] 
 
1.2.1.2. Tyrosine-Targeting Protein Modifications 
The aromatic amino acid tyrosine can also be targeted due to its reactive phenol side chain. As 
reported by Francis, !-allylpalladium complexes were used to address tyrosine residues in a 
selective fashion[30] by using palladium acetate. During this reaction, the !-allylpalladium 
complex was formed and subsequently reacted with the protein of interest. One characteristic 
feature of this method includes the cleavage of a “disposable group” upon the 
allyl-modification. This strategy was successfully applied to attach a lipophilic C17-allyl 



















Scheme4. Attachment of a lipophilic allyl chain onto myoglobin by targeting tyrosine 
residues via a water soluble allylation reagent.[30] 
 
1.2.2. SITE-DIRECTED CHEMICAL PROTEIN MODIFICATIONS 
1.2.2.1. Targeting a Cysteine via Maleimide Reagents 
Some proteins bear only one thiol group at their surface such as BSA, HSA and some 
antibody monomers. For example, BSA only has a single cysteine 34 on its surface; others are 
paired up to form disulfide bonds and are buried inside.  Upon modification with a 
maleimide reagent, Cys 34 could be site-specifically targeted. Nevertheless, this approach 
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usually affords a mixture of modified and unmodified protein since the conversion is not 
quantitative. This problem needs to be circumvented if we wish to prepare a pure modified 
protein via this approach.   
 
1.2.2.2. Targeting a Disulfide-Bond via Mono-/Bis-Sulfone Intercalation Reagents 
Recently, another method was established by Brocchini et al.[31] using disulfide intercalation 
reagent containing mono-/bis-sulfone groups. Site-specific modification has been achieved in 
such cases when there is only one accessible disulfide bond on the protein surface. This 
approach is based on the reduction of the accessible disulfide bridge and the reaction of the 
thiol groups with an appropriate mono-sulfone reagent via a double Michael addition 
mechanism to afford a bridged disulfide bond (Scheme 5). The major advantage of this 
scheme is the mild reaction condition and therefore, the protein’s tertiary structure and 
biological activity was maintained in most cases. This approach has been successfully used 
for site-specific PEGylation of cytokines, enzymes, antibody fragments and peptides[31]. A 
computational approach for the identification of the accessible disulfide bonds and prediction 
of the structural effects of such modifications are also available.[32]  
 
Figure4. Site-specific PEGylation of proteins using PEG-monosulfone reagent.[31] 
 
1.2.2.3. N-Terminal Modification of Proteins via Transamination 
In 2006, Gilmore et al. developed a relatively universal approach by targeting the N-terminal 
residue of proteins.[33] This method utilizes the unique reactivity of the N-terminal amine upon 
transamination. Therefore, N-terminal amino groups can be preferentially converted into a 
carbonyl group which can be afterwards conjugated with alkylhydrazine or alkoxyamine.  
The most efficient transamination reagent is pyrodoxal-5-phosphate (PPL). The two-step 
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modification process is shown below (Scheme 5).  






Scheme5. N-Terminal modification of proteins via transamination.[33] 
 
Since most proteins possess a free N-terminal amino group, this approach benefits from a 
broad application scope. However, there also exist some limitations. For example, this 
method is not suitable for proteins with N-terminal serine, cysteine, threonine or tryptophan 
residues due to their known side reactions with aldehydes/ketones. In addition, mixtures of 
native and modified proteins are generated and the separation of them is challenging due to 
their close molecular weight (M.W.). Furthermore, most of the proteins which were studied 
gave poor conversion ratios.[33] 
  
1.3. Enzyme-Mediated Site-Directed Protein Modification 
Application of post-translational enzymes in order to achieve site-directed protein 
modifications is also one promising way. This possibility has been explored by using 
transglutaminase II (TG II) to decorate RNase A and bovine pancreatic tyrosine inhibitor 
(BPTI) .[34] TG II is a posttranslational enzyme which has a remarkable specificity toward 
glutamine (Q) and lysine (K). Using dansyl-"-aminocaproyl-GlnGlnIleVal as substrate, TG II 
specifically attached this fluorescent Q probe onto the K1 residue of RNase A and to the K15 
residue of BPTI. Interestingly, no K residues on lysozyme C could be modified using TG2 
(Figure 5) which indicates that this approach somehow lacks predictability.  
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Figure5 a-c. K1 of RNase A and K15 of BPTI were selectively modified while no 
modification occurs on lysozyme under the catalysis of TG II.[34] 
 
1.4. Preparation of Reactive Rhodamine Dyes as Useful 
Chromophores for Protein Decoration 
In this section, functional rhodamine dyes that can be applied to decorate proteins and impart 
them with new functionalities will be discussed. The attachment of chromophores generally 
represents a straight-forward method to quickly assess how many substituents have been 
attached during a novel reaction scheme. In addition, chromophores have gained much 
interest for sophisticated dynamics studies of biomolecules in solution e.g. via FCS[18,19] and 
FRET[22,23] studies, for the development of chemosensors and cell imaging. Furthermore, 
chromophore-labeled proteins allow investigation of their dynamics in solution at the single 
molecule level[20], thus leading to an improved insight of e.g. structural rearrangements during 
enzyme catalysis or protein-protein interactions.  
 
Rhodamine B is one of the most widely used chromophores since it is cheap, water soluble 
and relatively photostable. However, derivatization strategies are still limited and there are 
only a few, very costly derivatives commercially available.  
 
1.4.1 FUNCTIONALIZATION OF RHODAMINE VIA RHODAMINE-PIPERAZIINE 
AMIDE INTERMEDIATES 
Rhodamine dyes are ionic chromophores which are prone to intramolecular cyclization under 
basic conditions. These features render the derivatization of rhodamines challenging. One 
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approach to address this problem is to convert rhodamines into rhodamine-piperazine amides 
intermediate, which can be easily derivatized further afterwards (Scheme 6). Via this method, 
several functional groups including carboxylic, hydroxyl, N-hydroxysuccinimidyl (NHS), 































X=Cl, I, SAc X=H, CO2-N-Succimidyl
or or
 
Scheme6. Derivatization of rhodamine B via rhodamine B-piperazine amide.[35] 
 
One limitation of this approach is the multi-step procedure where rhodamine was first 
converted to the rhodamine base, then transformed to rhodamine-piperazine intermediate and 
finally derivatized. In addition, the lipophilic piperazine ring linker hampers the water 
solubility of rhodamine, which represents a key concern in protein chemistry where good 
water solubility of conjugation reagents is preferred. Furthermore, the usage of dangerous 
trimethylaluminum limits the application of this approach.  
 
1.4.2. DERIVATIZATION OF RHODAMINE B TO RB-NHS ESTER (55) 
A more recent method is one-step conversion of rhodamine B into rhodamine B NHS ester 
applying coupling reagent dicyclohexylcarbodimide (DCC) (Scheme 7).[36] This protocol is 
relatively simple to yield an amine-reactive rhodamine dye. However, more attractive 
derivatives such as azido rhodamine, ethynyl rhodamine, and maleimide rhodamine cannot be 
achieved via this method. Therefore, the development of a facile, safe and versatile method 
toward useful rhodamine dyes represents a key concern. 




















Scheme7. Derivatization of rhodamine B (54) via RB-NHS (55) intermediate. 
 
In Results and Discussions section, our new research progresses in circumventing the above 
mentioned challenges in protein modification field as well as rhodamine derivatization area 
will be discussed accordingly. It includes a biology way toward site-directed protein 
modifications, two chemistry ways toward site-directed protein modifications and a facile 
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Chapter 2. RESULTS AND DISCUSSIONS 
 
2.1 The Biology SPI Approach towards Site-Directed Protein 
Modifications 
In this section, the biology SPI approach was applied to yield a bis-azido RNase A modified 
in a site-directed manner. The NCAA—AHA (2) was synthesized prior to the incorporation 
into RNase A. Subsequently, this amino acid was successfully inserted into the amino acid 
sequence of RNase A, thus yielding bis-azido RNase A with two AHA residues located at 
AHA 1 and AHA 41. 
 
2.1.1. SYNTHESIS OF AHA (2) 
AHA has emerged as a widely used NCAA that has been successfully incorporated into the 
amino acid sequence of a few native proteins, such as Candida antarctica lipase B[13] and 
ribonuclease A.[11] In this thesis, an optimized synthetic strategy of the originally published 
procedure has been elaborated and applied to produce larger amounts of AHA.[14] Based on 
this protocol, a significantly higher yield was achieved, which enabled the expression of 
RNase A for site-directed click-reactions. The whole reaction scheme is described in scheme 
8. 
NaN3, H2O




  CuSO4, H2O/MeOH
























Scheme8. 3-Step synthesis of AHA (2) via diazo transfer reaction. 
 
2.1.1.1 Synthesis of Triflic Azide (14) 
The synthesis of triflic azide is the first key step since triflic azide acts as the diazo transfer 
reagent which converts a primary amino group into an azido group. The synthesis starts from 
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the reaction of triflic anhydride with sodium azide at 0 oC in an aqueous media. According to 
our experimental results, the purity of the starting material—triflic anhydride (13), plays a 
key role to ensure a good yield of triflic azide. In order to achieve this, triflic anhydride 
requires purification via a so called “vacuum transfer” set up. Briefly, P2O5 was employed as 
the desiccation reagent and triflic anhydride was “distilled” at 0 oC, then solidified in a liquid 
nitrogen bath under high vacuum. The whole process is elaborated in the experimental part. 
Via this method, purified triflic anhydride was obtained. Subsequently, the successful 
preparation of triflic azide is indicated by the observation of an organic layer which settled at 
the bottom of the reaction vial. This organic layer is the desirable product—triflic azide—and 
can easily be isolated by extraction using dichloromethane (DCM). 
 
The major safety consideration in this synthesis is the highly reactive triflic azide as it is 
unstable, toxic, and extremely prone to explosion upon any slight shaking, grinding, 
pressurizing, concentrating or heating. Also, triflic azide must be used in a solution form 
rather than an isolated state. Therefore, the preparation and handling of this compound must 
be with great caution and a large scale synthesis of this reagent should be avoided. As a result, 
a separation funnel is not applicable for extraction but the combined use of test tubes and 
droppers is suitable.    
 
Triflic azide is unstable and is only effective for the next diazotransfer reaction when it is 
used immediately after preparation. The azide-containing waste needs to be disposed 
according to standard operation procedure (SOP) since azide waste is highly toxic to the 
environment.  
 
2.1.1.2 Synthesis of Boc-AHA (16) 
The second key step is the synthesis of Boc-AHA as the precursor of AHA. In this process, 
the amino group of N-Boc-2,4-diaminobutyric acid (Boc-Dab 15) was converted to an azido 
group by triflic azide under the catalysis of Cu2+ in basic conditions. Due to the different 
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solubility profile of Boc-Dab, triflic azide and cupper salt, a trinary solvent system was used 
which consisted of H2O, MeOH and DCM in a ratio of 1:2:1. In such a way, cupper salt, 
hydrophilic Boc-Dab and lipophilic triflic azide could somehow stay in a same phase thus 
speeding up the reaction. 
 
2.1.1.3 Deprotection of the Boc-AHA and Ion Exchange Purification of AHA (2) 
The deprotection of Boc-AHA proceeds smoothly using concentrated hydrochloric acid. The 
resultant product is further purified via cationic exchange chromatography. It should be noted 
that the loading of the cationic exchange resin should be sufficient in order to avoid the loss 
of AHA during the ion exchange purification. The obtained AHA is a white crystal with an 
average yield of 77 % which is obviously higher than the reported various yield of 34~59 %.  
 
2.1.1.4. Characterization of AHA (2) 
The final product AHA is characterized by ESI-MS, IR, 1H-NMR and 13C NMR. ESI-MS 
gives peaks of m/e 144.9 [M+H]+ and 143.0 [M-H]- which match the M.W. of AHA (144 
g/mol). IR (KBr) confirms the presence of azido groups in AHA due to the characteristic peak 
at 2110 cm-1 (Figure 6). 1H-NMR (D2O) showed the three sets of proton in AHA (Figure 6) 
and 13C-NMR (D2O) further supported the structure of AHA (see appendix).   









Figure6. IR and 1H-NMR (D2O) spectra of AHA (2).  
 
2.1.2. INCORPORATION OF AHA (2) INTO RNASE A (18) VIA SPI 
After successful preparation of AHA, this amino acid was incorporated as a methionine 
analogue into the amino acid sequence of RNase A using SPI. This piece of work was 
performed together with Joerg Wilhelmi and will be described in his thesis as well. After 
substitution of all methionine amino acids by AHA during SPI, an RNase with two accessible 
AHA-groups (called “bi-functional” RNase) was obtained. This RNase A variant was fully 
characterized by MALDI-ToF MS, gel electrophoresis and nanoLC-HR(ESI)MS/MS. The 
MALDI-ToF-MS spectrum of this protein reveals a characteristic signal with a M.W. of 15.77 
kD (Figure 7a). In parallel, the amino acid sequence information was revealed by 
nanoLC-HR(ESI)MS/MS of the in-gel digested protein sample. It shows that the two 
accessible AHA residues are AHA 1 and AHA 41. AHA 41 was located in close proximity to 
the active centre and the other one (AHA 1) was positioned at the N-terminus. The rest of the 
AHA residues were buried inside protein and are considered non-accessible for chemical 
reactions. The fidelity of AHA 1 and AHA 41 are determined to be 99.6 % and 97.8 %, 
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repectively (Figure 7b). 
 
Figure7 a-b. MALDI-ToF-MS spectrum of bis-AHA-RNase A (17) (a) and its 
aminoacid sequence informatioin revealed by nanoLC-HR(ESI)MS/MS (b). 
 
In summary, bis-azido RNase A with two AHA residues located at AHA1 and AHA41 was 
successfully prepared via the SPI appraoch. First of all, the NCAA, AHA, was synthesized 
with significantly enhanced yield and subseuqently, it was incorporated into the amino acid 
sequence of RNase A yielding the bis-azido RNase A variant. The M.W. of this variant was 
determined by MALDI-ToF-MS and its sequence information was retrieved from 
nanoLC-HR(ESI)MS/MS analysis of the in-gel digested protein sample.  
 
2.1.3. ATTEMPTS TOWARD THE SYNTHESIS OF AN “N-VALINE” DERIVATIVE 
(20) FOR THE INCORPORATION INTO RNASE A (18) 
Charges play a key role in fine-tuning the characteristics and the activity profile of proteins. 
For instance, it has been shown that the conversion of negatively charged carboxylic acid 
groups into primary amino groups yields a more “cationic” protein. Via this approach, the 
plasma protein BSA as well as RNase A were cationized, which strongly affected their ability 
to penetrate cell membranes.[29] In particular, cationic RNase A was able to cross cell 
membranes which enhanced its therapeutic profile as a promising anti-cancer agent.[37,38,39] In 
order to explore this possiblity, nitrogen containing amino acids (N-amino acids) were 
designed. They have a high likelyhood of being recognized by the translational machinery of 
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cell due to their high structural similarity to their corresponding native ones. In particular, the 










Figure8. Comparison of the structure between valine surrogate “N-valine” (20) and 
native L-valine. 
 
2.1.3.1. Synthesis of 20 via Reductive Amination 
The typical reductive amination involves the conversion of a carbonyl group into an imine 
intermediate. This reaction often takes place in situ where the formed imine was subsequently 
reduced into the amino group by a suitable reducing reagent. This reaction was considered 
worthwhile since the reduction agent selectively differentiates between the carbonyl starting 
material and the imine intermediate. In case a strong reducing reagent is applied such as 
lithium aluminum hydride, both the starting material and the imine intermediate will be 
reduced. Therefore, along with the formation of amino-products, an alcohol byproduct would 
be generated in parallel. One possibility to avoid this undesirable side reaction is to use a 
milder reducing agent that only attacks the more reactive imine-intermediate. Usually, sodium 
cyanoborohydride represents a good choice since the electron-withdrawing cyano group 
decreases the nucleophilicity of the hydride ion. In addition, water formed during the reaction 
needs to be removed in order to shift the equilibrium towards the product. Hence, activated 
4-Å molecular sieve or other desiccating reagents are often added to the reaction mixture.  
 
For our purpose, N,N-dimethyloxamic acid (19) was used as starting material. After the 
reduction of the carbonyl group, the target compound “N-Valine” (20) could be obtained in a 
one-step reaction according to the reaction scheme shown below (Scheme 9): 







NaCNBH3 (1.1eq), NH4OAc (10eq)






Scheme9. Attempts toward the synthesis of “N-Valine” (20) via reductive amination of 
N,N-dimethyloxamic acid (19). 
 
Unfortunately, after an overnight reaction at room temperature (RT), no product was detected 
according to LC-ESIMS analysis. Therefore, the reaction temperature was increased to 60 oC, 
but still, no product was detected. Then, different ammonium sources such as ammonium 
hydroxide, ammonium chloride and even the strong reducing reagent sodium borohydride 
were tested. Unfortunately, none of these experiments turned out to be successful. Further 
attempts to achieve 20 via this method were abandoned as a new synthetic scheme was 
proposed (Scheme 10). Probably the presence of the dimethylamino group of 19 deactivates 
its adjacent carbonyl group via the conjugation electron-donating effect. 
 
2.1.3.2. Synthesis of 20 via Bromination and Nucleophilic Substitution  
It was reported in Organic Synthesis (1993)[40] that Boc-glycine tert-butyl ester was 
brominated by N-bromosuccimide under UV irradiation using CCl4 as solvent. The 
brominated Boc-Gly-OtBu could in principle be converted into the desired N-valine after 
nucleophilic substitution with dimethylamine (Scheme 10). As CCl4 is a controlled chemical 














Scheme10. Synthesis of “N-Valine” (20) via radical bromination of Boc-Gly-OtBu (21) 
followed by nucleophilic substitution by dimethylamine. 
 
Five different solvents were screened including CHCl3, DCM, trichloroethylene, benzene and 
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chlorobenzene and for all reactions the reported procedure was strictly obeyed. Anhydrous 
benzene was used as purchased; all other solvents were pre-treated with activated 4Å 
molecular sieve before use. Unfortunately, none of the reactions yielded the brominated 
product according to LC-ESIMS and 1H-NMR analysis. Since reported similar bromination 
reactions all proceeded in CCl4 only, this radical bromination reaction might only work in 
CCl4. As a result, a third synthetic scheme employing phthaloglycine as a precursor was 
designed.  
 
2.1.3.3. Synthesis of 20 Using Phthaloglycine (24) as a Precursor  
Compared to N-Boc protected glycine (21), N-phthalo protected glycine (24) has a much 
higher chemical stability and the phthalo group can easily be deprotected under the treatment 
of con. HCl. The deprotected phthalo group is converted to phthalic acid precipitate which 
can easily be removed by filtration. In addition, the phthalimido group represents a tertiary 
amide that might not undergo any side reactions associated with the N-H bond on a secondary 
amide protection group.  
 
Three approaches were proposed. The first route was based on the Hell-Volhard-Zelinsky 
bromination reaction (Scheme 11, 25!28) whereby phthalimidoacetyl chloride (25) was 
treated with refluxing Br2. Unfortunately, according to 1H-NMR determination, the 
phthamidoacetyl chloride (25) remained unchanged. The second approach was the abstraction 
of the !-H of the phthaloglycine methyl ester (26) by sodium hydroxide followed by 
treatment with NBS. Similarly, this attempt was unsuccessful according to 1H-NMR analysis. 
We predicted that sodium hydroxide might not be strong enough to abstract the !-H of 
phthaloglycine methyl ester (26). In addition, NBS might not be the best bromine donor. 
Hence, we finally tried NaH combined with Br2 for the reaction. We expected that the NaH 
would be strong enough to abstract the !-H and the resulting anion would subsequently attack 
bromine to complete the bromination (Scheme 11, 26!27). Surprisingly, the starting material 
was totally unchanged after an overnight reaction.  
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Scheme11. Attempts toward the synthesis of “N-valine” (20) using phthaloglycine (24) 
as a precursor. 
 
In conclusion, the possibility of preparing  “N-Valine” via several distinct routes, such as 
reductive amination, bromination of Boc-Gly-OtBu, Hell-Volhard-Zelinsky reaction and 
bromination of phthaloglycine methyl ester, were explored. Although these attempts seem to 
be not satisfactory, meaningful results were acquired that might be helpful for future 
experiments within this project. Site-directed modifications of proteins via e.g. genetic 
engineering are certainly feasible, but they also suffer from several limitations. In this context, 
both SPI or nonsense codon suppression require not only the design of the respective NCAA, 
but also long time periods for protein expression. Furthermore, the yield of the corresponding 
protein is variable and might not be feasible to produce sufficient quantities for further 
investigations. Based on the above understanding, we were motivated to develop chemistry 
methods for site-directed protein modification which are more concise, time-saving and might 
afford larger quantities.  
 
2.2. Chemistry Approaches toward Site-Directed Protein 
Modification 
In this section, chemistry approaches, i.e. cysteine-targeting and lysine-targeting methods, for 
introducing site-directed protein modifications will be introduced. 
 
2.2.1. THE CYSTEINE-TARGETING APPROACH TOWARD THE S
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MONO-BIOTINYLATION OF HSA (33) 
Human serum albumin (HSA) is the most abundant protein in human blood plasma produced 
in the liver. It acts as a transportation protein in the body to carry thyroid hormones, fatty 
acids, unconjugated bilirubin etc. It also plays a key role in maintaining oncotic pressure.[46] 
Due to these facts, it is attractive to modify HSA in order to tune and alter its function. 
Among the 585 amino acid residues, cysteine 34 is a unique residue since it is the only 
unpaired cysteine present in the sequence and it is exposed to the surface thus allowing 
further chemical modifications. Reactions of free cysteine residues often involve Michael 
addition reactions applying maleimide derivatives as thiol-reactive group. Therefore, 
site-specific mono-modification of HSA is possible.  
 
In theory, the chemical reaction needs to proceed with quantitative yield since otherwise, a 
mixture of native and modified HSA will be formed. Unfortunately, conjugation with HSA 
using maleimides usually failed to reach 100 % conversion. Hence, the native HSA needs to 
be removed from the reaction mixture after chemical modification. One possibility to address 
this problem is based on the attachment of an affinity purification tag on the maleimide 
reagent. After the reaction, mono-modified HSA could be isolated via affinity purification and 
separated from the native HSA. 
 
Biotin was chosen as the affinity tag since biotin-containing proteins can be purified via 
Avidin affinity column due to the “quasi” reversible binding between biotin and the 
monomeric protein Avidin. Based on this principle, biotin-LC-maleimide (sheme12) was 
designed and synthesized. This novel reagent was subsequently reacted with HSA yielding the 
biotinylated HSA, which was purified by Avidin column.  






















DIEA, DMF, RT, 6h
pH 6.5, 1h
HSA (33) Biotinylated-HSA 













Scheme12. Synthesis of biotin-LC-maleimide (32) for mono-biotinylation of HSA (33). 
 
The success of this approach was demonstrated by MALDI-ToF-MS using sinapinic acid (SA) 
as the matrix. As shown in figure 5a, native HSA gives a M.W. of 66618 Dalton. After 
treatment of biotin-LC-maleimide and Avidin column purification, the modified protein 
shows a M.W. of 67097 Dalton (figure 5b). The M.W. increase (478 Dalton) closely matches 
the M.W. of biotin-LC-maleimide (480 Dalton).  
 
Figure9 a-b. MALDI-ToF-MS spectra of native HSA (33) (a) and mono-biotin-HSA (34) 
(b). 
 
This approach was proven successful for site-specific functionalization of protein. Using the 
reported protein database for molecular modeling, the proteins which have only a unique 
cysteine on their surface were identified. This protein series included serum albumins, histone 
proteins and some antibodies. Proteins under this category can be used for site-specific 
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modification by this protocol. If one protein does not show a surface cysteine, it could be 
modified after introducing a single surface-accessible cysteine group at a distinct position via 
site-directed mutagenesis. For other proteins which bear multiply accessible cysteines, this 
approach might not be applicable.  
 
However, this protocol suffers from the limitation that the scope of this method is relatively 
narrow. Hence, we explored the possibility of other more widely applicable functionalization 
protocols. 
 
2.2.2. N-TERMINAL FUNCTIONALIZATION OF RNASE A (18) VIA 
TRANSAMINATION 
2.2.2.1. Design of the Modification Protocol 
As mentioned in Introduction, J M Gilmore and M B Francis have reported the N-terminal 
protein modification via a biomimetic transamination reaction.[33] The N-terminal ! amino 
group was converted to a ketone or an aldehyde upon reaction with PPL. When a protein has 
an N-terminal glycine residue, the intermediate will be an aldehyde which allows additional 
reactions such as the Pictet–Spengler reaction.[34] We have tested three approaches for 
N-terminal modification of RNase A based on this rationale.  
 
All three routes were based on the transamination of RNase A to afford the activated RNase A 
with a ketone tag at the N-terminus (Scheme 13a). This keto-RNase A was subjected to three 
different reactions—(1) hydrazone formation, (2) an Aldol reaction and (3) a Pictet-Spengler 
reaction. The correspondingly designed reaction schemes are shown below. 



































b. Introduce an ethynyl group via hydrozone formation
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Scheme13a-d. Four designed routes toward N-terminal functionalization of RNase A 
(18) via transamination reaction. 
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In scheme b, the 4-hydrazinylbenzoic acid (37) is first equipped with an ethynyl group after 
treatment with 2-propynol to afford 4-hydrazinylbenzoic acid propargyl ester (38). This 
reagent further reacts with keto-RNase A (35) in order to yield a ethynyl-RNase A (39) via a 
hydrazone formation reaction. In scheme c, 3-hydroxy-4-nitrobenaldehyde (40) is introduced 
with an ethynyl group via Williamson etherification to afford 41. Subsequently, this 
ethynyl-benzaldehyde (41) reacts with keto-RNase A (35) to form the ethynyl conjugated 
RNase A (42) via an Aldol reaction. In the fourth scheme d, 5-bromotryptophan methyl ester 
(43) is converted to 5-ethynyltryptophan methyl ester (44) though a Sonogashira reaction. 
Then 5-ethynyltryptophan further reacts with keto-RNase A to form ethynyl-RNase A (45) via 
a Pictet-Spengler reaction.   
 
2.2.2.2. Experimental Results 
As a start, 4-hydrazinylbenzoic acid, 4-nitrobenzaldehyde and 5-bromotryptophan were 
employed to test the feasibility of all three routes. Both MALDI-ToF-MS and UV 
spectroscopy were used to assess product formation. Unfortunately, no protein was detected 
according to MALDI-ToF-MS or UV. According to the MALDI-ToF-MS spectrum, no 
protein peak was observed in the range of 14 kD (Figure 10 a). Similarly, in the UV 
absorption spectrum, no absorption was found indicating the absence of RNase A in the 
sample.  
 
Figure10 a-b. a. MALDI-ToF-MS spectra of the three reaction solutions (green: 
hydrazone reaction; red: Aldol reaction; blue: Pictet-Spengler reaction); b. UV 
spectrum of the three reaction solutions together with native RNase A. 
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2.2.2.3. The Explanation of the Failure of This Approach 
Based on these negative results, the protein activation step, i.e. the transamination reaction 
was reconsidered. A conversion of about 50% of RNase A during transamination was 
reported.[33] We hereby determined the UV and MALDI-ToF-MS of the keto-RNase A 
derivative (35), which was prepared strictly according to the reported procedure.[33] The 
results suggested that the first reaction step exhibits some problems. As a control, the 
MALDI-ToF-MS spectrum of a similar concentration of native RNase A (50mM) was also 
collected. Compared to the intensive mass peak at ~13.7kDa of native RNase A (Figure 11a), 
keto-RNase A only gives a faint mass peak at around 14 kDa (Figure 11b). Furthermore, the 
UV spectrum of keto-RNase A also shows the absence of the characteristic peak at 276nm 
(spectra not shown here). These data suggest that RNase A has decomposed during the 
transamination reaction. The failure of this method for the modification of RNase A might not 
occur in the functionalization of other proteins, for instance thioredoxin. According to the 
literature, thioredoxin shows a much higher conversion rate under the same conditions (~94 
%). However, since this approach proved to be not successful on RNase A, an alternative 
strategy was proposed targeting lysine residues. . 
 
Figure11 a-b. MALDI-ToF-MS spectrum of native RNase A (18, 50mM) (a) and 
keto—RNase A (35, ~50mM) (b). 
 
2.2.3. THE LYSINE-TARGETING APPROACH TOWARD THE 
MONO-BIOTINYLATION OF PROTEINS 
As most proteins bare multiple lysine residues on their surface, targeting a single lysine 
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without interfering with others appears to be challenging. For instance, according to some 
published results, modification of proteins targeting lysine leads to a heterogeneous 
mixtures.[32] However, as the lysine targeting approach benefits from the fact that it only 
requires mild reaction conditions, wide application scope etc., we were motivated to explore 
this possibility. 
 
First, we carefully examined the surface-exposed functional groups of proteins. With respect 
to lysine residue, we raised the question whether all surface lysine groups are equally exposed 
at the surface and whether they are equally accessible by amino-reactive reagents. In addition, 
we wondered whether all lysine residues had the same interaction with their environment, for 
instance H-H bonding. If not, surface lysines might display different activity toward 
amine-reactive reagents and the most reactive lysine might be selectively targeted using a 
tailored bioconjugation reagent.   
 
2.2.3.1. Evaluation of the Solvent Accessibility of Lysine Residues of RNase A (18) 
Again, RNase A has been chosen as a model protein since it is of medium size, is a 
well-characterized enzyme, is stable, and has been explored as a potential effective anti-tumor 
therapeutic.[37,41,42,43] First the distribution of lysine residues was examined applying the 
molecular modeling software MOE (molecular operation environment) (PDF file: 1RCA). As 
revealed by the 3D structure, RNase A possesses as many as ten lysines residues and nine out 
of ten are accessible on the surface except lysine 41 which is located in the active centre 
(Figure 12). Among these nine surface lysines, K1 exhibits the highest accessibility according 
to the calculation by MOE. 
Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 30 
 
Figure12. The crystal structure of RNase A (20) (PDB file: 1RCA) where Lys 1 is 
highlighted by green spheres whereas other accessible lysine residues are indicated 
in yellow except the solely buried Lys 41 shown in bright blue; the substrate of RNase 
A, 2’-Deoxycytidine-2’-deoxyguanosine -3’-5’-monophosphate (CGP), is indicated in 
mauve. 
 
Furthermore, we examined the interactions of K1 together with other surface lysines, with 
other residues in close vicinity based on its crystal structure. According to our study, no 
obvious interactions, such as H-H bonding were revealed. This precludes the possibility that 
residue interactions might affect the activity of lysine. Therefore, we predicted that the K1 
residue might be preferentially targeted when RNase A is treated with an amine-reactive 
reagent such as NHS ester. 
 
2.2.3.2. Several Considerations Concerning Site-Directed Modifications 
There are several considerations for designing the modification reagent and choosing the 
appropriate reaction conditions. Firstly, the modification reagent needs to be active enough to 
react with the protein smoothly at low concentrations. Secondly, water–solubility of the 
bioconjugation-reagent is preferred for protein modifications in aqueous media. Thirdly, the 
modification reagent should be present in limited quantities during the reaction in order to 
ensure mono-functionalization of RNase A. A mixture of native RNase A and modified RNase 
A will be formed under such reaction conditions. Therefore, the presence of an affinity 
purification tag on the reagent is necessary for later separation.  
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2.2.3.3. Design and Synthesis of Biotin-PEG-NHS (49) 
Based on the before-mentioned considerations, biotin-PEG-NHS (49, scheme 14) was 
designed and synthesized. The biotin moiety represents an affinity tag while the PEG chain 
contributes to water-solubility. The NHS-ester is known to be a very active reagent that 











































Scheme14. Synthetic scheme of biotin-PEG-NHS (49). 
 
2.2.3.4. Mono-Biotinylation of RNase A (18), Lysozyme C (50) and SST (51) 
RNase A, lysozyme C and Somatostatin (SST) were tested based on this method (Scheme 15). 
Basically, the protocol involves the addition of 0.5 equiv. of biotin-PEG-NHS solution in 100 
portions into each protein solution stepwise (1 equiv.) during a two hours period. We expected 




















  RNase A or Lysozyme C
  or Somatostatin (1 equiv.)
Monobiotinylated Protein/Peptide
0.5 equiv.
1.PBS (pH 7.2), 2h, RT





Scheme15. Mono-biotinylation of RNase A (18), lysozyme C (50) and SST (51) in the 
lysine-targeting approach. 
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The reaction solution of each protein was subjected to MALDI-ToF-MS analysis using SA as 
the matrix. In agreement with our hypothesis, all three proteins/peptides gave a mixture of 
native and mono-modified protein, as revealed by their MALDI-ToF-MS spectra (Figure 13) 
 
Figure13 a-c. MALDI-ToF-MS spectra of the reaction mixture of RNase A (18) (a), 
lysozyme C (50) (b) and SST (51) (c). 
 
Subsequently, the reaction mixture was treated with ethanolamine to quench any remaining 
biotin-PEG-NHS. The resultant solutions were first purified by gel filtration to remove 
biotin-containing small molecules in the sample. Finally, the two proteins, biotin-PEG-RNase 
A and biotin-PEG-lysozyme C were further purified via affinity chromatography using Avidin 
resin. Purified proteins were characterized by MALDI-ToF-MS and biotin-PEG-RNase A 
displayed a single peak at m/z 14138 (calcd. m/z 14134).  On the other hand, 
biotin-PEG-lysozyme C shows a major peak at m/z 14728 (calcd. m/z 14734) and a minor 
peak located at the left which indicates the presence of some native lysozyme C. This 
problem which is due to its non-specific binding to the Avidin column could be addressed in 
principle by using a fresh batch of Avidin resin. The final protein product can be further 
purified via a second gel filtration to remove biotin and salt and lyophilized to afford the 
powder form. 
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Figure14 a-b. Biotin-PEG-RNase A (52) shows a M.W. of 14.14 kD in the 
MALDI-ToF-MS spectrum and biotin-PEG-Lysozyme C (53) displays a M.W. of 14.73 
kD. 
 
In conclusion, a novel and facile protein mono-functionalization method has been developed 
which targets lysine residues. This approach contains four major steps as described in figure 
15. First of all, the native protein was treated with a biotin-conjugation reagent to generate 
mono-biotinylated protein which contains native protein (Figure 15, step a). Subsequently, a 
quencher solution was added to decompose unreacted biotin-conjugation reagent followed by 
the first gel filtration to remove the deactivated biotin-containing small molecules (Figure 15, 
step b and c). Thirdly, mono-biotinylated protein was “fished” up from the solution via 
affinity chromatography based on the reverse binding between the biotin group and the 
monomeric Avidin, thus achieving the separation between modified and unmodified proteins. 
In the last step, the biotin and salt which stayed in the protein solution after affinity 
chromatography were removed via a second gel filtration and finally lyophilized to generate 
our product as a powder form. It is worthwhile to note that from a mixture of native and 
modified protein to biotinylated protein, native protein is also recovered and can participate in 
the next modification circle (Figure 15, dark blue arrow). 
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Figure15. The four major steps involved in the lysine-targeting approach for 
mono-modification of proteins.  
 
In all, we expect that this method has a broad application scope since it targets 
surface-exposed lysine residues which typically exist on most protein surfaces. In addition, 
we predicted that the most reactive lysine residue was preferentially addressed during the 
mono-modification process based on the consideration of solvent-accessibility as well as the 
residue interactions in close vicinity. As a potential application, this method can be applied to 
introduce a single bioorthogonal functional group onto a protein via bioorthogonal 
conjugation reagents thus opening up the opportunity to further decorate proteins via click 
reactions.   
 
2.3. A Novel Synthetic Method towards Rhodamine B Derivatives for 
Protein Labeling 
After the successful introduction of functional groups into the protein scaffold in a 
site-directed fashion via three distinct approaches—the biology SPI approach, the cysteine 
targeting, and the lysine targeting chemistry approach—we were further motivated to develop 
reactive chromophores to label these modified proteins. This piece of work is scientifically 
attractive as these chromophores can impart new functionalities on proteins and enable further 
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investigation of them via FCS, FRET or other analytic techniques. In the following section, 
we focus on the derivatization of rhodamine B dye as it is commercially available and 
displays a higher photostability than some of other dyes such as fluorescien etc. 
 
2.3.1. RB DERIVATIZATION BY REACTING WITH AMINES 
It has been reported that rhodamine dyes can be derivatized via rhodamine-piperazine amide 
intermediate.[44] This method is generally applicable. However, due to the multiple reaction 
steps involved and usage of the hazardous reagent trimethylaluminum, the application of such 
method is still restricted. Hence, an alternative strategy has been suggested in this thesis, 
which is considered greener and safer. 
 
2.3.1.1 Reaction of RB-NHS (55) with Primary Amines 
Rhodamine B possesses a single free carboxylic acid group which could be targeted for 
derivatization reactions. One straightforward way is to directly let rhodamine B reacts with 
amines. Hence, our initial attempts are focused on the reaction of rhodamine B (54) with 
propargylamine to afford rhodamine B propargyl amide (56). To achieve this goal, rhodamine 
B was first activated to NHS ester via DCC coupling. The purified NHS ester was later 












































Scheme16. Synthesis of RB-propargyl amide (56) affords a pseudo product (57) due 
to the intramolecular cyclization.  
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A light pink powder was obtained after RB-NHS (55) reacted with propargylamine. The 
1H-NMR spectrum appeared to match with the anticipated product, RB propargyl amide (56) 
since both the rhodamine B moiety and the propargyl group could be identified individually 
in the 1H-NMR spectrum. Also, the ESI-MS analysis seems to be in agreement with its M.W., 
m/z 480 [M+] (calcd. m/z 480). Interestingly, two characteristic properties of rhodamine B 
were missing. The product became water insoluble which indicated the loss of its ionic nature. 
In addition, this compound had a light pink color rather than dark violet as we expected. This 
observation suggests the absence of the conjugated xanthene system. Hence, it can be 
concluded that the pseudo-rhodamine B propargyl amide (57) was formed instead of the 
anticipated product (56) via an intramolecular cyclization reaction (Scheme 14). Such a 
pseudo-rhodamine B propargyl amide (57) has an identical ESIMS value and a similar 
1H-NMR spectrum compared to rhodamine B propargyl amide (56) but it is not water soluble 
nor violet.  
 
We also tried to couple RB-glycine (72) with propargylamine via DCC coupling. A colorless 
mixture was obtained whose ESI-MS data indicated that it was a mixture of pseudo-RB 
glycine amide (58, m/z 500 [M+H] +) and pseudo RB-Gly propargyl amide (59, m/e 537 
[M+H]+) (Scheme 14).  
 
All this experimental data suggested that the N-H group of the secondary amide bond in the 
expected product (e.g. 56) tends to insert into the xanthene ring system to form the pseudo 
products via intramolecular cyclization. Therefore, we believe that replacement of a primary 
amine by a secondary amine as the starting material can circumvent this problem since a 
tertiary amide bond will be formed which will prevent the intramolecular cyclization. This 
approach will be discussed in the following section. 
 
2.3.1.2. Reaction of RB-NHS (55) with Secondary Amines 
Unlike N-propargylamine, N-methyl-N-propargylamine is a secondary amine which contains 
Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 37 
one more methyl group on its nitrogen atom. Therefore, it was chosen to react with RB-NHS 
applying the same procedure in order to prepare ethynyl-rhodamine B (Scheme 17). This 
route proved to be successful since a dark violet solid was obtained and the LC-ESIMS 























61 62  
Scheme17. Secondary amines react with RB-NHS (55) to afford products 60, 61 and 
62 but with some impurities.  
 
However, this product was found to contain some impurities which cannot easily be removed 
via a normal workup procedure and column chromatography techniques. The same situation 
was encountered when applying N-methyl-N-ethylamine and piperazine as the starting 
material. In principle, this problem could be overcome by using Prep-HPLC, but it will be 
costly and is uneasy to achieve large quantities. Because of this, a more successful and facile 
route was developed via one step Steglich esterification.  
 
2.3.2. ONE-STEP FUNCTIONALIZATION OF RHODAMINE B VIA STEGLICH 
ESTERIFICATION 
2.3.2.1. Synthesis of Rhodamine B Ethyl Ester (60) 
Finally, we have explored the possibility of applying the Steglich esterification for rhodamine 
B derivatization. In the model reaction, rhodamine B was reacted with EtOH using DCC as 
the coupling reagent under the catalysis of DMAP (Scheme 18). 
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Scheme18. Synthesis of rhodamine B ethyl ester (60) via DCC-coupled Steglich 
esterification. 
 
This DCC-coupled Steglich esterification proceeded very well in the synthesis of rhodamine 
B ethyl ester (60). A pure product was obtained as a violet crystal after workup and silica gel 
flash chromatography. LC-ESIMS gives 98.5 % purity (Figure 16) with m/z 471.15 [M+] 
(calcd. 471.26). The structure of this rhodamine B ethyl ester was further confirmed by 
1H-NMR and 13C-NMR. 



































Figure16. HPLC spectrum of rhodamine B ethyl ester (60) reveals a purity of 98.5 % 
(256 nm). 
 
2.3.2.2. Synthesis of Rhodamine B Propargyl Ester (73) for Antibody Labeling 
With this protocol in hand, we first tried to synthesize rhodamine B propargyl ester for 
labeling the azido-proteins. Applying the same protocol, rhodamine B reacted with propargyl 
alcohol affording a pure rhodamine B propargyl ester in the form of a violet crystal.  
 
This dye was used as a protein probe to label azido-3F11 which is a 25 kD antibody 
(monomer) functionalized with an azido group via copper catalyzed azide-alkyne 
cycloaddition (CuAAC, also known as Huisgen 1,3-dipolar cycloaddition) (Scheme 19a).  
Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 39 
Gel electrophoresis results indicated the success of the labeling as the click product gave an 
intensive fluorescence band at 25 kD (bottom, monomer) and a faint fluorescent band at 50 
kD (top, dimmer). In contrast, the azido-antibody (N3-AB) band at neither 25 kD nor 50 kD 
showed no fluorescence at all.   
 
Scheme19 a-c. a. Label azido-3F11 using rhodamine B propargyl ester (73) via 
CuAAC; b. gel electrophoresis image of azido-3F11 (N3-AB) and the click product 
(coomassie blue stain); c. fluorescence image of the electrophoresis gel of both 
N3-AB and the click product. 
 
2.3.2.3. Synthesis of Rhodamine Azidoethyl Ester (63) as an Ethynyl Reactive 
Chromophore 
The third rhodamine B derivative synthesized is rhodamine B azidoethyl ester. 
2-Bromoethanol was reacted with sodium azide to form 2-azidoethanol which was 
subsequently reacted with rhodamine B to afford azido-rhodamine B. The synthetic scheme is 
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Scheme20. Synthetic scheme of rhodamine B azidoethyl ester (63). 
 
Rhodamine B azidoethyl ester can be used to label ethynyl-proteins via a click reaction. We 
first tested such possibility by reaction this azido-rhodamine B with 5-ethynyltryptophan 
ethyl ester (Scheme 21). HR-ESIMS and 1H-NMR confirmed the formation of the product. 
Applying a similar reaction condition, rhodamine B azidoethyl ester successfully labeled 
ethynyl-BSA (data not shown). This reaction has been applied to test the number of accessible 
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ethynyl groups on BSA by calculating the UV absorption ratio between the characteristic 
peaks of rhodamine B and BSA.  
O














CuSO5, NaAscbt   t-BuOH-H2O
RT, overnight
M.W. 512.7 M.W. 256.1 M.W. 768.4
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Scheme21 a-b. a. Huisgen 1,3-dipolar cycloaddition reaction between 
azido-rhodamine B (63) and 5-ethynyltryptophan ethyl ester (64); b. ESI-MS spectrum 
of the clicked product (65). 
 
2.3.2.4. Synthesis of Monosulfone-OH Rhodamine B Ester (69) as a Disulfide-Reactive 
Chromophore 
The fourth rhodamine B derivative prepared was a disulfide-reactive chromophore, called 
monosulfone-rhodamine B. This dye can be used to label proteins possessing accessible 
disulfide bonds. In addition, by determining the mass increase of the labeled protein, the 
number of accessible disulfide bonds could be assessed. The synthesis of this dye started with 
the reaction of bisulfone-NHS ester with ethanolamine to afford monosulfone-ethanol. This 
intermediate subsequently reacted with rhodamine B via Steglich esterification to give 
monosulfone-rhodamine B in the form of a violet solid (Scheme 22). This chromophore was 
successfully used to label SST which is a disulfide bridged cyclic peptide known as a growth 
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Scheme22. Synthesis of monosulfone-OH rhodamine B ester (69) for bioconjugation 
with the cyclic peptide SST (51). 
 
In conclusion, four rhodamine B derivatives were prepared via one step Steglich esterification. 
They proved to be efficient protein probes for labeling functionalized proteins/peptide such as 
azido-antibodies and SST. This strategy is concise (one step only) and safe (it avoids the 
usage of dangerous reagents) compared to previously reported methods. We hope that our 
results could serve as bases to achieve rhodamine B bearing attractive functionalities suitable 



















Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 42 
Chapter 3. EXPERIMENTAL SECTION 
 
1H and 13C-NMR spectra were recorded with a Bruker AV 300, a Bruker AMX 500 or a 
Bruker DRX 500 NMR spectrometer operating at 300 MHz for 1H and 75.48MHz for 13C 
NMR. Chemical shifts were reported in ppm (# scale) relative to the solvent signal, and 
coupling constant (J) values were reported in hertz (Hz). High-resolution mass spectra 
(HRMS) were recorded on a Finnigan MAT95XL-T mass spectrometer by direct infusion of 
the solution of each compound using electrospray ionization (ESI) in positive or negative 
mode. LC-ESIMS were recorded by a Schmadzu 
LC-20AD/SPD-20A/SIL-20AC/LCMS-2010EV using the C-18 column and MeCN/H2O as 
eluent. UV spectra were recorded by a BioTEK SYNERGY 4 Microplate Reader. 
MALDI-ToF-MS was determined by a Bruker auto-Flex spectrometer. Chemicals were 
purchased from Sigma-Aldrich, Merck and Regent and used without further purification 
unless otherwise stated. Dowex 50 W!4 cationic exchange resin was purchased from 
Sigma-Aldrich (Fluka, Na+ form, 200-400 mesh, category No. 44473). And the PreHPLC 
machine was distributed from Gilson. 
 
3.1. Triflic Azide (14) Solution 
3.1.1. PURIFICATION OF TRIFLIC ANHYDRIDE (13)  
It is a prerequisite that triflic anhydride (13) is purified prior to its usage in order to remove 
any hydrolyzed impurities. Since 13 is very sensitive and considered to be a very hazardous 
compound, the following “vacuum transfer” apparatus was set up, including a 50 ml RBF, a 
Schlenk flask, a stirring bar and a 3-way tube with 2 stopcocks. 
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Figure17. The “vacuum transfer” setup includes a 50 ml RBF, a Schlenk flask, a 
stirring bar and a 3-way tube with 2 stopcocks. 
 
Briefly, the whole apparatus was thoroughly heated and dried in vacuum in advance. Then 
P2O5 (0.25 g) and triflic anhydride (2.5 ml) were placed in a 50 ml RBF under Ar atmosphere 
and stirred for 10 hours overnight. The originally yellowish triflic anhydride became milk 
yellow upon adding the P2O5 then completely faded away after stirring overnight. Using such 
“vacuum transfer” methodology, triflic anhydride was solidified in the Schlenk flask which 
was cooled by a liquid nitrogen bath. About 1.7 ml freshly purified triflic anhydride was 
obtained with a yield of 68 %. This freshly prepared liquid was immediately used in the 
following reaction in order to avoid any delay. 
 
3.1.2. TRIFLIC AZIDE (14) SOLUTION 
The preparation of triflic azide (14) solution, Boc-AHA (16) and AHA (2) is a continuous and 
multiple step process. In favor of a clear description of the whole protocol, each single step 
has been numbered in the following.  
[1] Prepare a 100 ml Schlenk flask with NaN3 (1.3 g, 20 mmol) and H2O (3.2 ml) inside, and 
then place it in an ice bath. 
[2] Add dropwise the purified triflic anhydride (0.664 ml, 4 mmol) into the flask which 
contains sodium azide from step 1. Then remove the ice bath and allow the reaction mixture 
to stir at RT for two hours. 
[3] At the completion of the reaction in step 2, there will be a layer settled at the bottom of the 
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RBF which indicates the formation of triflic azide. Transfer the reaction mixture to a big test 
tube and rinse the RBF with DCM (2 ml) which is combined with the reaction mixture in the 
big test tube subsequently. After separation, the DCM layer in the big test tube is isolated and 
the remaining aqueous phase is extracted twice more with DCM (2 ml ! 2) using the same 
procedure.  
[4] Combine the organic layers and wash them in a big test tube with brine (6.4 ml) and a 
saturated NaHCO3 solution. Shake and allow the emulsion to separate. Collect the DCM layer 
by a dropper which is the triflic azide solution in DCM. As this solution is unstable at RT, it 
should be used in the following diazotransfer reaction as soon as possible.  
 
According to the standard operation procedure (SOP) of NaN3 waste, all aqueous waste 
generated in this reaction should be disposed accordingly as NaN3 is a highly poisonous for 
the environment, particularly for aqueous organisms. 
  
3.2. Boc-AHA (16) 
[5] During the two hour period in step 3, add Boc-Dab (436 mg, 2 mmol), K2CO3 (416 mg, 3 
mmol) and a catalytic amount of CuSO4·5H2O (5 mg, 0.02 mmol) into a clean 100 ml RBF 
equipped with a stir bar. To this RBF add 6.4 ml of H2O to dissolve the reactants with 
ultrasonication. Finally, add 12.8 ml of MeOH to this RBF and shake; the resultant solution 
will be basically clear. Set this flask aside until the triflic azide is prepared. 
[6] Add the TfN3/DCM solution from step 5 dropwise to the flask prepared in Step 3. The 
reaction solution will be, in the main, clear with a light-blue color. The reaction mixture is 
stirred at RT overnight. 
[7] The following day, remove the MeOH and DCM via rotary evaporation at 40 oC leaving 
behind about 6.4 ml of aqueous solution. This solution will be bright blue and basic (pH 
9~10) 
[8] Add 6 M HCl by a dropper slowly to the solution until the pH reaches 6. Note that upon 
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the pH reaching 9 the solution begins to turn green; bubbles are released upon the pH 
reaching 8 and finally the solution will become slightly cloudy and yellowish with a little of 
green upon the pH reaching 6. 
[9] Dilute the solution with 24 ml of phosphate buffer composed of 0.25 M KH2PO4 and 0.25 
M K2HPO4 (pH 6.2). Readjust the pH of the entire mixture to 3 by adding 6 M HCl dropwise. 
[10] Extract the aqueous solution in a separatory funnel twice with EtOAc (2!24 ml). 
[11] Combine the EtOAc layers and wash them with brine (12 ml). Dry over anhydrous 
MgSO4 (2.4 g) for 30 min, then filtrate and remove the EtOAc by rotary evaporation at 40 oC. 
This will afford 609 mg (on average) of semisolid as the product.  
1H-NMR (CDCl3, 300MHz): # 5.49(d, J=7.2Hz, br, 1H), 4.22(m, 1H), 3.35(t, J=6.7Hz, 2H), 













ESI-MS (-): C9H15N4O4- calcd. 243.1, found 243.0 
 
3.3. AHA (2) 
The obtained Boc-AHA (16) is treated with con. HCl to yield the target amino acid AHA (2). 
 
[12] Dissolve the semisolid product from step 11 in 1.24 ml of concentrated HCl and stir at 
RT for 1 h. 
[13] Dilute the solution with 11.2 ml of water. 
[14] Pack an ion exchange column by adding Dowex cationic exchange resin (16.7 g) to a 
glass chromatography column of a suitable size under the assistance with MQ-H2O. 
[15] Condition the resin by washing it three times with 1 M NH4OH (72 ml), once with 
DI-H2O (890 ml), once with 1 M HCl (72 ml) and once with DI-H2O (890 ml) again. The 
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column eluent should be slightly acidic. 
[16] Add the solution from step 13 to the column, collect the flowthrough and pass it over the 
column twice more. If any AHA can be detected in the flowthrough by TLC/ninhydrin, a 
higher loading of cationic resin is required. 
[17] Wash the column with water (595 ml) until the pH of the eluent remains constant (pH 
6-7). 
[18] Elute the amino acid from the column by adding 1 M NH3.H2O (149 ml). 
[19] Remove the aqueous NH4OH using a rotary evaporator at 55 oC leaving behind 223 mg 
(on average) of colorless clumpy crystal as the product in a yield of 77 %.  

















ESI-MS (-): C4H7N4O2- cacld. 143.1, found 143.0 
IR (KBr/cm-1): 2119.07 (azido group) 
 
3.4. The Reaction Conditions in Reductive Amination of 
N,N-Dimethyloxamic Acid (19) to afford “N-Valine” (20) 
The first reaction condition: N,N-dimethyloxamic acid (117 mg, 1 mmol), NaCNBH3 (69.3 
mg, 1.1 mmol), NH4OAc (770 mg), dry MeOH (dried over 4 Å molecular sieve, 4.76 ml, 0.21 
M) and 1 g activated 4 Å molecular sieve were added into a 25 ml Schlenk flask under Ar 
atmosphere. This reaction suspension was allowed to stir at RT overnight and was monitored 
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by TLC and LC-ESIMS. 
The second reaction condition: an additional 1 g of 4 Å molecular sieve was added and the 
reaction temperature was increased to 60 oC and stirred for an additional 24 h. 
The third reaction condition: this reaction was performed in a similar way but equal 
equivalent of NaBH4 or NH4Cl or NH4OH (aq.) were used to replace the corresponding 
reagents.   
 
3.5. The Reaction Condition in Bromination of N-Boc-Gly-OtBu (21) 
In a dried 25 ml-Schlenk flask N-Boc-Gly-OtBu (100 mg, 0.433 mmol), NBS (81.3 mg, 0.457 
mmol, freshly recrystallized from water), and dry solvent (CHCl3, DCM, benzene, 
chlorobenzene or tetrachloroethylene, 1.75 ml) were combined under Ar atmosphere. The 
Schlenk flask was cooled in a 9 oC water bath and irradiated by a 300-W tungsten lamp. The 
temperature of the water bath was maintained by continuous addition of ice. The temperature 
inside the Schenk flask was maintained at 15 oC. This was controlled by a thermometer put 
inside. The reaction was allowed to proceed for 1 h and monitored by LC-ESIMS and 1H- 
NMR. 
 
3.6. Phthaloglycine (24) 
Into a 250 ml RBF equipped with a Dean-Stark trap and a condenser, glycine (7.51 g, 100 
mmol), phthalic anhydride (14.2 g, 100 mmol), Et3N (1.6 ml, 10 mmol) and toluene (60 ml) 
were placed. The reaction mixture was heated to reflux for 6 h with azeotropic removal of 
water. Toluene was removed by evaporation under reduced pressure. The residue was 
dissolved in 150 ml H2O and acidified by adding con. HCl (2 ml, 22 mmol). The product was 
collected by filtration, washed with water (2!10 ml) and dried in vacuo to give 19.3 g of 
phthaloglycine (24) as a white solid in a yield of 94.2 %. 
1H-NMR (CDCl3, 300MHz): # 7.89(m, 2H), 7.75(m, 2H), 4.47(s, 2H) 













ESI-MS (-): C10H6NO4- calcd. 204.0, found 203.9  
 
3.7. The Reaction Condition in Bromination of Phthaloglycine (24) 
via the Hell-Volhard-Zelinsky Reaction 
Into a 25 ml-Schenk flask, phthaloglycine (2.05 g, 10 mmol) and SOCl2 (4 ml) were added 
under Ar atmosphere. The reaction mixture was heated to reflux for 1.5 h and excess of SOCl2 
was removed under vacuum. The 1H-NMR spectrum confirmed the formation of the 
intermediate product—phthalimidoacetyl chloride (25). Liquid bromine (0.64 ml) was added 
to the RBF in an Ar atmosphere and the reaction mixture was heated to reflux overnight and 
monitored by 1H-NMR. 
 
3.8. Phthaloglycine Methyl Ester (26) 
Into a 25 ml Schlenk flask equipped with a condenser, phthaloglycine (2.05 g, 10 mmol) and 
SOCl2 (4 ml) were placed and refluxed for 1.5 h. Then, MeOH was added into the flask and 
heated to gentle reflux. After excess of SOCl2 and MeOH were removed under vacuum the 
residue was taken up in the EtOAc. The organic layer was washed with sat. NaHCO3, water 
and brine, dried over anhydrous Na2SO4, filtrated and the EtOAc was evaporated under 
reduced pressure. The product was dried in vacuo to afford 200 mg of white solid as 
phthaloglycine methyl ester (26) in a yield of 6.7 %. 












Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 49 
 
3.9. The Reaction Conditions in the Bromination of Phthaloglycine 
Methyl Ester (26) Using NBS/NaOH 
The first reaction condition: into a 2-necked 25 ml RBF equipped with a condenser and a stir 
bar phthaloglycine methyl ester (26) (110 mg, 0.5 mmol), NBS (93.4 mg, 0.525 mmol, 
recrystallized), NaOH (120 mg, 3 mmol) and dry DMF (2.5 ml) were added in an Ar 
atmosphere to form a yellow-colored mixture. The reaction mixture was stirred at 80 oC 
overnight and monitored by LC-ESIMS. 
The second reaction condition: the temperature was subsequently increased to 150 oC and 
stirred for 22 h. The reaction was monitored by LC-ESIMS.  
 
3.10. The Reaction Condition in the Bromination of Phthaloglycine 
Methyl Ester (26) Using Br2/NaH 
Into a thoroughly dried RBF equipped with a stir bar NaH (60 % in mineral oil, 1.2 equiv.) 
and dry THF (1 ml) were added and the suspension was cooled to 0 oC by an ice-water bath. 
A solution of phthaloglycine methyl ester (50 mg) in dry THF (0.5 ml) was injected dropwise 
to this reaction suspension and stirred at 0 oC for 20 min. Then, a solution of Br2 (15.8 "l) in 
dry THF (0.5 ml) was added dropwise into the reaction mixture and stirred at 0 oC for 20 min. 
The reaction was monitored by LC-ESIMS as well as 1H-NMR.  
 
3.11. Biotin-LC-Maleimide (32) 
Into a small Eppendorf tube 6-biotinamindohexanoic acid NHS ester (biotin-LC-NHS, 8.0 mg, 
17.6 "mol), maleimidoethylamine trifluoroacetic acid salt (4.9 mg, 19.4 "mol), 
N,N-diisopropylethylamine (DIEA) (3.67 "l, 21.1 "mol) and dry DMF (176 "l, 0.2 M) were 
combined. The Ependorff tube was capped and fixed in a shaker via a conical flask and was 
shaken at RT for 6 h until the LC-ESIMS indicated that the full conversion of the starting 
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material to the product had been accomplished. The reaction mixture was dissolved in 
MeCN/DMF/H2O to form a homogeneous solution and the target compound (32) was purified 
by PrepHPLC (#max 205 nm) to afford 8.2 mg of white solid product in a yield of 97 %.  
1H-NMR (DMSO-d6, 300MHz): # 7.85(t, J=5.9Hz, 1H), 7.72(t, J=5.4Hz, 1H), 7.00(s, 2H), 
6.41(s, 1H), 6.38(s, 1H), 4.30(t, J=6.3Hz, 1H), 4.12(t, J=5.3Hz, 1H), 3.43(t, J=5.8Hz, 2H), 
3.18(q, J=5.9Hz, 2H), 3.10(m, 1H), 2.98(m, 2H), 2.82(dd, J1=12.3Hz, J2=5.1Hz, 1H), 2.57(d, 
























13C-NMR (DMSO-d6, 300MHz): # 172.22, 171.72, 170.96, 162.62, 134.43, 60.99, 59.15, 
55.35, 38.26~48.34(overlap with DMSO peaks), 37.20, 36.62, 35.72, 35.24, 35.17, 28.92, 






























HR-ESIMS (+): C22H33N5NaO5S+ calcd. 502.2095, found 502.2113 
 
3.12. Monobiotinylation of HSA (33) via the Cysteine-Targeting 
Approach 
To a degassed solution of HSA (68 mg, 1 µmol) in a phosphate buffer (60 ml, 50 mM, pH 
6.5), a freshly prepared aqueous solution of TCEP (0.22 ml, 1 mM, 0.22 µmol) was added in 
an Ar atmosphere and the reaction mixture was stirred for ten minutes at RT. Then a solution 
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of biotin-LC-maleimide (1 mg) in DMSO (1 ml, 2 µmol, 200 % excess) was added and the 
reaction mixture which was stirred at RT for 1 h in an Ar atmosphere. The non-reacted 
biotin-LC-maleimide was removed after five times ultra-filtration with water and 
size-exclusion chromatography (Bio-Gel P 30, MQ-H2O). Thereafter, unmodified HSA was 
removed via affinity chromatography by applying the Softlink Avidin Resin (Promega) 
according to its published protocol.  
MALDI-ToF-MS (native HSA): m/e 66619 [M+H]+  
MALDI-ToF-MS (maleimide-HSA): m/e 67098 [M+H]+ 
 
3.13. The Reaction Condition in the Transamination of RNase A (18) 
to Afford keto-RNase A (35) 
The following reagents were prepared prior to the start of the experiment: phosphate buffer 
(50 mM, pH 6.5), 10 "M RNase A (1.35 mg/ml in phosphate buffer), and 20 mM of 
pyrodoxal-5-phosphate (4.94 mg/ml in phosphate buffer). These reagents were freshly 
prepared and stored at 4 oC prior to use.  
 
0.5 ml of RNase A solution was mixed with an equal volume of pyrodoxal-5-phosphate 
solution in a 1.5 ml Eppendorf tube and incubated at 37 oC for 44 h. The resulting solution 
was dialyzed against MQ-H2O to remove excess pyrodoxal-5-phophate. The purified 
keto-RNase A solution was kept at 4 oC before proceeding to the next step. Theoretically, the 
concentration of the activated RNase A solution contained 50 "M of protein (0.675 mg/ml) 
since the solution volume doubled after the dialysis. 
MALDI-ToF-MS (SA): calcd. 13.7 kD, found ~14 kD (br) 
 
3.14. The Reaction Condition in the Hydrazone Formation of 
Keto-RNase A (35) 
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The freshly prepared keto-RNase A was treated with an equal volume of 4-hydrazinylbenzoic 
acid solution (100 mM in HOAc/H2O (1:1)) at 37 oC for 24 h. The resulting solution was 
dialyzed against MQ-H2O and the product was monitored by MALDI-ToF-MS (SA). 
 
3.15. The Reaction Condition in the Aldol Reaction of Keto-RNase A 
(35) 
The freshly prepared keto-RNase A was treated with 80 "l of DMSO solution and 
4-nitrobenzaldeyde (10 mM) at 37 oC overnight. The removal of small molecules from the 
reaction mixture was achieved by gel filtration (Sephadex-G15 gel) before being monitored 
by MALDI-ToF-MS (SA).  
 
3.16. The Reaction Condition in the Pictet-Spengler Reaction of 
Keto-RNase A (35) 
25 "l of the freshly prepared keto-RNase A (18) was combined with 7.2 "l of 
5-bromotryptophan methyl ester solution (68 "M in DMSO). The reaction mixture was 
incubated at 37 oC for 24 h and dialyzed against MQ-H2O and monitored by MALDI-ToF-MS 
(SA). 
 
3.17. 5-Bromotryptophan Methyl Ester (43) 
Into a 25 ml 2-neck RBF 5-bromotryptophan (46.4 mg, 145 "mol) and 5 ml of MeOH were 
added under anhydrous conditions. The RBF was placed into an ice bath until the temperature 
of the reaction mixture was cooled to 0 oC. Thereafter, SOCl2 (1 ml) was added dropwise and 
the ice water bath was detached. The reaction mixture was stirred at RT for 24 h until the TLC 
indicated the complete consumption of the starting material. SOCl2 and MeOH were removed 
under high vacuum and dried overnight in vacuo to give 50.9 mg of solid as the product in a 
yield of 95 %.  
Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 53 
1H-NMR (DMSO-d6, 300MHz): # 11.45(s, 1H), 8.73(s, 3H), 7.71(s, 1H), 7.35(d, J=8.1Hz, 
















13C-NMR (DMSO-d6, 300MHz): # 170.0, 135.3, 129.2, 127.1, 123.9, 120.8, 114.0, 111.7, 



















ESI-MS (+): C12H14BrN2O2+ calcd. 297.0, found 296.9 
 
3.18. Biotin-LC-OH (71) 
Biotin-LC-NHS (31) (3.6 mg, 0.009 mmol) was dissolved in DMSO-d6 (0.5 ml) and 
transferred into a NMR tube. Subsequently, ethanolamine (30 mg, 0.49 mmol) was added to 
the solution and the solution was shaken vigorously. The NMR tube was capped, sealed by 
parafilm, fixed on a conical flask via a robber stopper and shaken at RT for 24 h. 1H-NMR 
and ESI-MS indicated the complete consumption of the starting material which can be seen 
from the disappearance of the NHS ester signal.  
 
Excess of ethanolamine and DMSO-d6 were removed in vacuo overnight at RT. The residue 
was dissolved in 1 ml of MeOH/MeCN (1:1) and further purified by Prep-HPLC 
(tR=10.1~12.2 min, #=205 nm) to give 1.6 mg of white solid as the product (71) in a yield of 
44 %. 
1H-NMR (DMSO-d6, 300MHz): # 7.78(t, J=5.6Hz, 1H), 7.73(t, J=5.6Hz, 1H), 6.41(s, 1H), 
6.35(s, 1H), 4.68(sb, 1H), 4.30(td, J1=5.1Hz, 1H), 4.12(td, J1=4.6Hz, 1H), 3.33(m, 2H), 
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3.10(m, 2H), 3.08(m, 1H), 2.99(q, J=6.5Hz, 2H), 2.82(dd, J1=12.3Hz, J2=5.0Hz, 1H), 2.59(d, 























1.17~1.61 1.17~1.61  
13C-NMR (DMSO-d6, 300MHz): # 172.5, 172.1, 163.1, 61.4, 60.3, 59.6, 55.8, 41.8, 




























ESI-MS (+): C18H33N4O4S+ calcd. 401.2, found 401.2[M+H]+  
 
3.19. Biotin-PEG-COOtBu (47) 
(+)-Biotin (93.4 mg, 0.393 mmol) and EDC·HCl (110 mg, 0.573 mmol) were introduced into 
an aluminum foil coated 5 ml RBF and were dried in vacuo. Then dry DMF (3.8 ml, 0.05 M) 
was injected at 0 oC followed by the dropwise injection of tert-butyl-12-amino-4,7,10- 
trioxadodecanoate (80 % purity, 53 "l, 0.191 mmol). The reaction mixture was stirred at 0 oC 
for 0.5 h and then allowed to warm to RT and stirred for 40 h. TLC indicated the complete 
consumption of the starting material and the LC-ESIMS spectrum revealed the formation of 
the target product (47). 
 
The reaction mixture was concentrated at RT under vacuum and taken up in DCM. The 
organic phase was washed three times with DI-H2O, once with 0.1 M HCl to remove the trace 
of basic impurities, once with DI-H2O and finally, mixed with saturated Na2CO3 solution. 
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Later, the organic layer was separated and the aqueous phase was extracted twice by DCM. 
The Organic layers were combined, washed with brine, dried over anhydrous Na2SO4, 
filtrated and concentrated. Final purification via silica gel flash chromatography 
(CHCl3:MeOH 5:1, I2 stain) gave 51.4 mg of light yellow solid as the product (47) in a yield 
of 67 %. All steps were performed under the exclusion of light since biotin is considered to be 
a light sensitive species. 
1H-NMR (DMSO-d6, 300MHz): # 6.71(t, br, 1H), 5.85(s, 1H), 5.49(s, 1H), 4.41(m, 1H), 
4.26(m, 1H), 3.63(t, J=6.2Hz, 2H), 3.53(m, 8H), 3.45(t, J=5.5Hz, 2H), 3.27(q, J=5.6Hz, 2H), 
3.12-3.18(m, 1H), 2.87(dd, J1=12.6, J2=5.0, 1H), 2.63(d, J=12.8Hz, 1H), 2.40(t, J=6.2Hz, 2H), 


























13C-NMR (DMSO-d6, 300MHz): # 173.69, 171.64, 164.20, 80.76, 70.90, 70.85, 70.72, 

























ESI-MS (+): C23H41N3NaO7S+ calcd. 526, found 526 
 
3.20. Biotin-PEG-COOH (48) 
Biotin-PEG-COOtBu (47) (75 mg, 0.147 mmol) was dissolved in DCM (1.73 ml) and 
transferred into a 25 ml RBF under Ar atmosphere. The solution was cooled in an ice-water 
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bath and TFA (0.87 ml) was added dropwise. The ice-water bath was removed and the RBF 
was wrapped with aluminum foil to exclude light. The reaction mixture was allowed to warm 
to RT and incubated overnight. DCM and TFA were removed under high vacuum leaving 
behind a white solid as the product 48 in a quantitative yield.  
1H-NMR (DMSO-d6, 500MHz): # 7.81(s, 1H), 6.49(s, br, 2H), 4.31(m, 1H), 4.13(m, 1H) 
3.60(t, J=6.3Hz, 2H), 3.49(s, br, 8H, PEG H), 3.39(t, J=6.0Hz, 2H), 3.18(q, J=8.2Hz, 2H), 
3.09(m, 1H), 2.82(dd, J1=12.6Hz, J2=5.05, 1H), 2.58(d, J=12.6Hz, 1H), 2.53(t, J=6.3Hz, 2H), 
1.60(m, 1H), 1.49(m, 2H), 1.43(m, 1H), 1.29(m, 2H).  
13C-NMR (DMSO-d6, 500MHz): 172.58, 172.10, 162.70, 69.69, 69.68, 69.60, 69.53, 69.14, 
66.21, 61.04, 59.21, 55.37, 39.75, 38.44,35.06, 34.72, 28.15, 28.00, 25.22 
HR-ESIMS (+): C19H33N3NaO7S+, cacld. 470.1931, found 470.1952 
 
3.21. Biotin-PEG-NHS (49) 
Into an aluminum foil coated 5 ml RBF equipped with a stir bar, Biotin-PEG-COOH (40.0 mg, 
0.71 mmol), EDC·HCl (26 mg, 0.136 mmol) and N-hydroxysuccinimide (NHS) (13.6 mg, 
0.12 mmol) were added. This mixture was dried under vacuum for 45 min before dry DMF 
(0.46 ml, 0.15 M) and DIEA (15.6 "l, 0.096 mmol) were introduced. The reaction solution 
was allowed to stir at RT for 23 h until TLC indicated the disappearance of the starting 
material and the formation of a new spot (CHCl3: MeOH, Rf(SM) 0.4, Rf(P) 0.6, I2 stain). 
 
Thereafter, the solvent was removed at RT under vacuum and the viscous liquid was 
partitioned in CHCl3/H2O (3/1, V/V). The organic layer was collected by a dropper. The 
aqueous layer was extracted six times by CHCl3. The organic layers were combined and 
washed with brine, dried under vacuum, purified by silica gel flash chromatography (CHCl3: 
MeOH, 5:1, I2 stain) to produce 24.1 mg of white solid 49 in a yield of 62 %. 
1H-NMR (MeOD, 500MHz): # 4.49(t, J=6.2Hz, 1H), 4.31(t,m,1H), 3.84(t, J=5.95, 2H), 
3.62(t,m, 8H),3.54(t, J=5.3Hz,2H), 3.35(t, J=5.3Hz,2H), 3.21(m, 1H), 2.9(m, 2H), 2.84(s, 
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4H), 2.69(m, 2H), 2.22(t, J=7.3Hz, 2H), 1.73(m, 1H), 1.65(m, 2H), 1.59(m, 1H), 1.44(m, 2H). 
13C-NMR (MeOD, 500MHz): # 176.12, 171.69, 168.59, 166.08, 71.63, 71.61, 71,47, 71.26, 
70.57, 66.86, 63.36, 61.62, 56.97, 41.04, 40.37, 36.74, 32.95, 29.48, 26.82, 26.52. 
DEPT135 (MeOD, 500MHz): # (+) 63.36, 61.62, 56.97; (-) 71.63, 71.61, 71.47, 71.26, 70.57, 
41.04, 40.37, 36.74, 32.95, 29.74, 29.48, 26.83, 26.52. 
ESI-MS (+): C23H36N4NaO9S+ calcd. 567.2, found 567.3 
 
3.22. Monobiotinylation of RNase A (18), Lysozyme C (50) and SST 
(51) via the Lysine-Targeting Approach  
3.22.1. MATERIALS 
Some of the materials which were required for this reaction were prepared as described below 
and have been numbered individually.  
[1] Dissolve biotin-PEG-NHS (49) (2.66 mg) in MQ-H2O (133 ml, 0.02 mg/ml) to prepare a 
36.3 "M reagent solution. This should be freshly prepared in order to avoid the hydrolysis of 
this NHS ester in aqueous solution. Keep at 4 oC.  
[2] Dissolve RNase A (1.28 mg) in a 0.1 M PBS buffe (pH 7.2, 1.28 ml) to afford a 72.5 "M 
protein solution (1 mg/ml). Keep at 4 oC. 
[3] Dissolve lysozyme C (2.44 mg) in a 0.1 M PBS buffer (pH 7.2, 2.3 ml, 1.06 mg/ml) to 
afford a 72.5 "M protein solution. Keep at 4 oC. 
[4] Similarly, dissolve SST in a PBS buffer to afford a 0.12 mg/ml peptide solution whose 
molar concentration is also 72.5 "M. Keep at 4 oC. 
 
3.22.2. MODIFICATION PROTOCOL 
The lysine targeting approach for the site-directed modification of proteins/peptide contains 
four major steps as detailed below. 
 
3.22.2.1. Step I: Bioconjugation 
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In this step, mono-biotinylated proteins/peptide were formed. This is a protein mixture in 
buffer. 
  
Into an autoclaved Falcon tube containing the protein/peptide solution (1 ml), 
biotin-PEG-NHS (49) solution (1 ml) was added portion-wise at a rate of 8.4 "l/min within 2 
h. The reaction mixture was incubated at RT for an additional 1.5 h and the solution was 
subjected to MALDI-ToF-MS for analysis (Figure 13). According to the MALDI-ToF-MS 
spectrum, all three proteins/peptide were monofunctionalized, thus a mixture of native and 
modified proteins/peptide were formed in a PBS buffer solution.  
 
3.22.2.2. Step II: Quenching 
The reaction mixture contained unreacted biotin-PEG-NHS (49) which will interfere with the 
mono-modified protein after affinity chromatography. In order to deactivate any unreacted 
biotin-PEG-NHS (49), the following quenching step was applied.  
 
Ethanolamine is a water soluble primary amine which can readily react with any NHS esters 
in aqueous media. Hence, an ethanolamine solution was employed in this step. The 
ethanolamine solution (2.67 mg/ml, 0.5 "l) in MQ-H2O (1.33 "g, 1.2 equiv.) was added to 
each protein sample and incubated for 4 h. Ethanolamine will quench the unreacted 
biotin-PEG-NHS conjugation reagent.  
 
3.22.2.3. Step III: Affinity Chromatography 
Mono-biotinylated proteins/peptide were “fished” up from the reaction solution thus 
achieving the separation between modified and non-modified proteins/peptide. Since the 
presence of any biotin-containing reagent in the protein solution will block the active binding 
pockets of monomeric Avidin resin, they must be removed before affinity chromatography via 
e.g. gel filtration. 
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Procedure for Gel Filtration: 
[1] Activate the Sephadex G15 gel (1.5 kD MWCO, 12 g) by dispersing it in MQ-H2O (45 ml) 
in a 45 ml Falcon tube overnight. 
[2] Divide the gel suspension into three equal portions and used it to pack three gel filtration 
columns. 
[3] Elute each gel filtration column by MQ-H2O until the eluent no longer displays any UV 
absorption. 
[4] Load each reaction solution (1 ml) onto a separated column and eluted with MQ-H2O. 
Collect around eight fractions of 1 ml each. 
[5] Assay all fractions under UV absorption and combine the protein fractions.  
 
Procedure for Affinity Chromatography: 
Prior to affinity chromatography, the following materials/reagents were prepared: 
  1. Resin: Promega Softlink Avidin Resin (cat. No. V2011, 1ml). 
  2. Columns: 3 pieces of 1ml syringes without plungers and with a small piece of cotton at 
the bottom to hold the bed. 
  3. Buffer A: fresh 0.1 M NaPO4 buffer (pH 7.0), prepared by dissolving 156 mg of  
NaH2PO4·2H2O and 222 mg of Na2HPO4 in 25.6 ml of MQ-H2O. 
4. Buffer B: fresh PBS buffer (0.1 M) obtained by diluting a 1 M PBS buffer 10-times in 
MQ-H2O. 
5. Regeneration Buffer: 10 % acetic acid in water (V/V). 
6. Elution Buffer: fresh 5 mM biotin/PBS solution prepared by dissolving 12.2 mg of biotin 
in a 10 ml Buffer B. 
7. Blocking Buffer: fresh 5 mM biotin/NaPO4 (0.1 M) prepared by dissolving 12.2 mg of 
biotin in a 10 ml Buffer. 
8. Preservative Solution: 20 % EtOH in water, used for the storage of the column. 
 
The whole affinity purification procedure consists of the following four major steps. 
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Step 1: block the irreversible binding pockets of the Avidin resin using a Blocking Buffer. 
1. Pack the resin column with 0.25 ml of bead for each column. 
2. Equilibrate the three columns with Buffer A. 
3. Wash each column with Blocking Buffer at least two column volumes. 
4. Stop flow for 15 min. 
Step 2: regenerate the column 
1. Wash each column with eight column volumes of Regeneration Buffer. 
2. Wash each column with eight column volumes of Buffer A. 
3. After the pH of eluent increased to pH 6.8, stop the flow for a minimum of 30 min to 
allow the Avidin to refold. 
4. Equilibrate the column with Buffer B. 
Step 3: purification 
1. Load a 2 ml sample in each column. 
2. Wash with 5 column volumes of Buffer B. 
3. Elute each biotin-PEG-protein/peptide with Elution Buffer.  
4. Collect fractions for each column with 0.4 ml per fraction. 
5. Assay each fraction by applying a BioTEK microplate reader to identify the modified 
proteins/peptide solution.  
Step 4: storage 
   1. Elute each column with Preservative Solution, and then stop the column. 
   2. Store the column at 4 oC. 
 
3.22.2.4. Step IV: Gel Filtration 
Since the isolated protein is dissolved in the Elution Buffer which contains biotin molecules 
and salt, they should be removed from the protein prior to storage. This can be achieved via 
gel filtration as described before in this section followed by freeze drying. Lyophilized protein 
powder was properly stored at -80 oC. 
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3.23. Rhodamine B NHS Ester (RB-NHS) (55) 
In a typical reaction, rhodamine B (3.0 g, 6.28 mmol) and NHS (0.75 g, 6.52 mmol) were 
placed into a 250 ml 3-neck RBF equipped with a condenser and a 50 ml dropping funnel. 
Then dry MeCN (100 ml) was added into the flask and it was heated to 45 oC. A solution of 
DCC (1.5 g, 7.35 mmol) in dry MeCN (50 ml) was added dropwise. After stirring at 45 oC for 
1 h, the reaction solution was cooled to RT and stirred for 21 h more. Thereafter, the reaction 
was cooled at 4 oC overnight to precipitate N,N’-dicyclohexylurea (DCU) from the reaction 
mixture. The reaction mixture was filtrated, removed of MeCN under reduced pressure and 
dried in vacuo to give 3.66 g of dark green crystals as the product in a quantitative yield.  
1H-NMR (CDCl3, 300MHz): # 8.41(dd, J1=7.1Hz, J2=1Hz, 1H), 7.97(td, J1=7.1Hz, J2=1Hz, 
1H) 7.81(td, J1=7.3Hz, J2=0.8Hz, 1H), 7.47(dd, J1= 7.1Hz, J2=0.8Hz, 1H), 7.07(d, J=10.1Hz, 




















13C-NMR (CDCl3, 300MHz): # 168.7, 160.6, 157.6, 155.5, 155.5, 134.8, 134.2, 131.5, 130.9, 


























ESI-MS (+): C32H34N3O5+ calcd. 540.3, found 540.3 
 
3.24. Rhodamine B-Glycine Amide (72) 
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In a typical reaction, glycine (45.0 mg, 0.6 mmol) was dissolved in 1.8 ml of H3BO3 buffer 
(pH 8.5, 0.05 M) and the aqueous solution was stirred while a solution of RB-NHS (36 mg, 
0.0626 mmol) in MeCN (1.8 ml) was added slowly to the buffer solution. After continuous 
stirring at RT for 4 h, MeCN was removed under reduced pressure. A violet precipitate was 
obtained and further recrystallized from EtOH/H2O to afford 3.8 mg of rhodamine B glycine 
amide (72) in the form of a bright violet crystal with a yield of 11 %.  
1H-NMR (CDCl3, 300MHz): # 7.91(dd, J1=6.2Hz, 1H), 7.45(m, 2H), 7.08(m, 1H), 6.48(d, 
J=8.9Hz, 2H), 6.36(d, J=2.3Hz, 2H), 6.26(dd, J1=8.9, J2=2.3Hz, 2H), 3.85(s, 2H), 3.31(q, 
















ESI-MS (+): C30H34N3O4+ calcd. 500.25, found 500.34 
 
3.25. Pseudo-Rhodamine B Propargyl Amide (57) 
The synthetic route of pseudo-rhodamine B propargyl amide is similar to rhodamine glycine 
amide (section 3.2.1). The reaction scheme is shown below. A pink white powder was 










H3BO3 Buffer (pH8.5, 0.05M) (3.5ml), RT, 4h
(80ul), MeCN(3.5ml)
70mg pink white powder  
1H-NMR (CDCl3, 300MHz): # 7.92(m, 1H), 7.43(m, 2H), 7.10 (m, 1H), 6.47 (d, J=8.9Hz, 
2H), 6.39 (d, J=2.6Hz, 2H), 6.27 (dd, J1=8.9Hz, J2=2.6Hz, 2H), 3.95 (d, J=2.6Hz), 3.33 (q, 
J=7.1Hz, 8H), 1.76(d, J=2.5Hz, 1H), 1.16 (d, J=7.1Hz, 12H). 
















ESI-MS (+): C31H34N3O2+ cacld. 480.3, found 480.3 
 
3.26. Rhodamine B Ethyl Ester (60) 
The synthesis procedure of rhodamine B ethyl ester is similar to the synthesis of rhodamine B 
propargyl ester (section 3.2.4). The quantity and equivalent of each reagent is given by the 
reaction scheme below. Starting from 479 mg of rhodamine B (1 mmol), 112.9 mg of violet 








EtOH   (87.5ul, 1.5mmol)
EDC    (288mg, 1.5mmol)
DMAP (24.4mg, 0.2mmol)
DCM   (dry, 5ml, 0.2M)
0C 45min, then room temp.
479mg, 113mg obtained  
1H-NMR (CDCl3, 300MHz): # 8.07 (d, J=7.6Hz, 1H), 7.60 (t, J=7.3Hz, 1H), 7.52 (t, J=7.5Hz, 
1H), 7.08 (d, J=7.0Hz, 2H), 6.87 (d, J=9.1Hz, 2H), 6.72(d, J=9.4Hz, 2H), 6.59 (s, 2H), 3.85 

















13C-NMR (CDCl3, 300MHz): # 164.41, 158.27, 157.07, 154.90, 132.80, 132.40, 130.70, 
129.78, 129.51, 113.71, 112.88, 95.60, 60.88, 45.60, 13.20, 12.10 
























LC-ESIMS (10%~100% MeCN, 20min, 256nm): tR 7.76min, 98.5% purity; C30H35N2O3+ 
calcd. 471.26, found 471.15 
 
3.27. Rhodamine B Propargyl Ester (73) 
Into a 25 ml 2-neck RBF equipped with a condenser, rhodamine B (1.91 g, 4 mmol), DCC 
(989 mg, 4.8 mmol), DMAP (97.6 mg, 0.8 mmol), DCM (121 ml) and 2-propynol (0.28 ml) 
were combined. The reaction mixture was stirred at RT for 2 h. Then the reaction mixture was 
filtrated to remove DCU, washed twice with 6 M HCl and brine, dried over anhydrous 
magnesium sulfate and filtrated. The solvent was removed under reduced pressure and the 
product was dried in vacuo to afford 9 mg of 73 in the form of dark violet crystals with a 
yield of 27 %.  
 
1H-NMR (CDCl3, 300MHz): # 8.30(dd, J1=7.7Hz, J2=1.1Hz, 1H), 7.83(td, J1=7.5Hz, 1.2Hz, 
1H), 7.73(td, J1=7.7Hz, J2=1.3Hz, 1H), 7.31(dd, J1=7.6Hz, J2=1.1Hz, 1H), 7.04(d, J=9.5Hz, 
2H), 6.89(dd, J1=9.5Hz, J2=2.5Hz, 2H), 6.80(d, J=2.3Hz, 2H), 4.60(d, J=2.5Hz, 2H), 3.63(q, 
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13C-NMR (CDCl3, 300MHz): # 164.1, 158.1, 157.6, 155.4, 133.6, 133.4, 131.4, 131.0, 130.3, 
























HR-ESIMS (+):C31H33O3N2+ cacld. 481.2486, found 481.2471 
EA: C31H33O3N2Cl·2H2O calcd. C 67.32%, H 6.74%, N 5.06%, Cl 6.41%; found C 67.46%, H 
6.71%, N 5.14%, Cl 6.94%;  
UV-Vis (H2O): $max 559 nm, " 1.43!105 M-1·cm-1 
 
3.28. Azidoethanol (62) 
Into a 5 ml RBF 2-bromoethanol (375 mg, 3.03 mmol), NaN3 (257 mg, 6.1 mmol) and the 
phase transfer catalyst n-Bu4NBr (25 mg, 0.075 mmol) were combined. The mixture was 
heated to 110 oC and stirred for 15 h. Afterwards the reaction mixture was cooled to RT and 
diethyl ether (1 ml) was added. The precipitate which contained NaBr, NaN3 and n-Bu4NBr 
was removed by filtration and the crude solid was washed three times with diethyl ether. The 
ether layers were combined and dried in vacuo to afford 36.2 mg of yellowish liquid as the 
product 62 in a yield of 13.6 %. During the vacuum drying, the product was also lost which 
resulted in a poor yield. This can be circumvented by using rotavap instead of high vacuum 
for the drying.  
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The 1H-NMR of the starting material—2-bromoethanol—was also determined for the 
comparison with the product. The up-field shift clearly suggested the substitution of the 
bromo group by an azido group. 






3.29. Rhodamine B Azidoethanol Ester (63) 
2-Azidoethanol (62, 26.2 mg, 0.30 mmol) was dissolved in anhydrous DCM to form a stock 
solution. Rhodamine B (141 mg, 0.30 mmol), DCC (97 mg, 0.45 mmol) and 
4-dimethylaminopyridine (DMAP, 9.2 mg, 0.075 mmol) were placed into a 10 ml RBF which 
was wrapped by an aluminum foil and capped by a rubber stopper. The reaction mixture was 
further dried in vacuum and charged with Ar through a needle. Then 2-azidoethanol/DCM 
solution was injected by a syringe at 0 oC. Afterwards the reaction mixture was stirred, 
allowed to warm up slowly to RT and further stirred for 6 h. Subsequently, DCM was added 
and the reaction mixture was washed by water (2!), HCl (5!, 6 M), brine (1!), and 
concentrated to 3 ml. The organic layer was cooled at 4 oC to precipitate DCU from the 
solution. After filtration, the filtrate was evaporated and dissolved in 3.2 ml MeCN (HPLC 
grade). Half of the obtained sample was purified via PrepHPLC (#=256 nm) to afford 24.3 mg 
of 63 in the form of a violet crystal with a yield of 43 %.  
1H-NMR (CDCl3, 500MHz): # 8.31 (dd, J1=7.6Hz, J2=too tiny, 1H), 7.81(dd, td, J1=7.6Hz, 
J2=too tiny, 1H), 7.75(td, J1=8.2Hz, J2=1.3Hz, 1H), 7.32(dd, J1=7.6Hz, J2=too tiny, 1H), 
7.07(d, J=9.5Hz, 2H), 6.92 (dd, J1=9.5Hz, J2=2.6Hz, 2H), 6.82(d, J=2.5Hz, 2H) 



















13C-NMR (CDCl3, 500MHz): # 164.75, 158.37, 157.79, 155.60, 133.63, 133.34, 131.49, 
























ESI-HRMS(+): C30H34N5O3+ calcd. 512.2656, found 512.2639 
UV-Vis (H2O): $max 559 nm; " 1.48!105 M-1.cm-1 
 
3.30. 5-Ethynyltryptophan Rhodamine B Conjugate (65) 
Rhodamine B azidoethanol ester (63, 1.8 mg, 6.9 "mol) was added to a test tube equipped 
with a rubber stopper in an Ar atmosphere. Thereafter, 45 "l of a solution of 
5-ethynyltryptophan (64) /tBuOH (1.8 mg, 7.0 "mol) was injected, followed by the addition 
of 90 "l H2O. Then, 0.7 "l of a freshly prepared solution containing CuSO4 (18 "g, 0.07 "mol) 
and sodium ascorbate (69 "g, 0.35 "mol) were injected. After the test tube was detached from 
the Schlenk line, the rubber cap was sealed by parafilm and the test tube was coated with 
aluminum foil to exclude light. This tube was fixed in a suitable conical flask and shaken at 
RT overnight until LC-ESIMS indicated full conversion of the starting material (63) to the 
product (65). The reaction mixture was dissolved in 1.5 ml of MeCN/H2O and purified by 
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PrepHPLC (# 254 nm) to afford the pure product. 
1H-NMR (CDCl3, 500MHz): # 10.31(s, 1H), 8.37 (m, 1H), 8.03(s, 1H), 7.91(s, 1H), 7.78(m, 
1H), 7.76(m, 1H), 7.49(m, 1H), 7.43(m, 1H). 7.15(m, 1H), 6.90(m, 2H), 6.62(m, 2H), 6.60(m, 
2H), 4.55(s, br, 4H), 4.14(t, J=11.8Hz, 2H), 4.00(s, br, 2H), 3.69(s, br, 1H), 3.21(s, br, 2H), 




























HR-ESIMS (+): C45H50N7O5+ calcd. 768.3868, found 768.3877 
UV-Vis (H2O): $max 564 nm, " 2.12!105 M-1.cm-1 
 
3.31. Bisulfone-OH (68) and Monosulfone-OH (67) 
Into a small Ependorff tube 4-(3-tosyl-2-(tosylmethyl)propanoyl)benzoic acid 
N-hydroxysuccinimidyl ester (bisulfone-NHS, 66) (20.2 mg, 34 "mol), DMF (340 "L, 0.1 M) 
and ethanolamine (30.5 "l, 51 "mol) were combined and the Ependorff tube was sealed and 
fixed on a conical flask with a rubber cap. The reaction mixture was shaken at 180 r/min at 
RT overnight (~18 h). Then, the reaction mixture was taken up in MeCN/H2O/MeOH and 
purified by PrepHPLC to afford 4.2 mg of 68 in the form of a white solid with a yield of 23 %. 
De-toslated product—N-(2-hydroxyethyl)-4- (2-(tosylmethyl)acryloyl)benzamide 
(monosolfone-OH, 67) was also isolated and characterized. 
1H-NMR (CDCl3, 300MHz): # 7.78(d, J=8.6Hz,2H), 7.70(d, J=8.0Hz, 2H), 7.69(d, J=8.2Hz, 
4H), 7.36(d, J=7.9Hz, 4H), 4.37(m, 1H), 3.87(t, J=4.9Hz, 2H), 3.67(d, J=4.6Hz, 2H), 3.62(dd, 
J1==14.3, J2=6.6Hz, 2H), 3.49(dd, J1=14.3Hz, J2=5.9Hz, 2H), 2.48(s, 6H) 






















13C-NMR (CDCl3, 300MHz): # 195.20, 167.02, 145.58, 139.07, 136.48, 130.22, 128.81, 






















ESI-MS (+): C27H30NO7S2+ calcd. 544, found 544 
1H-NMR (CDCl3, 500MHz): # 7.84(d, J=8.2Hz, 2H), 7.78(d, J=8.2Hz, 2H), 7.73(d, J=8.2Hz, 
2H), 7.32(d, J=7.6Hz, 2H), 6.67(s, br, 1H), 6.29(s, 1H), 5.99(s, 1H), 3.87(t, J=2.2Hz, 2H), 




















13C-NMR (CDCl3, 500MHz): # 194.11, 167.33, 145.13, 138.89, 137.76, 135.93, 135.84, 
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HR-ESIMS (-): C20H20NO5S- cacld. 386.1068, found 386.1082 
 
3.32. Monosulfone-OH Rhodamine B Ester (69) 
Into a 2 ml test tube, monosulfone-OH (67) (1.6 mg, 4.13 "mol), rhodamine B (2.97 mg, 6.2 
"mol), DCC (1.28 mg, 6.2 "mol), and DMAP (0.13 mg, 1.1 "mol) were combined and this 
mixture was dried in vacuo for half an hour. Later, dry DCM (100 "l, 0.04 M) was introduced 
via a syringe at 0 oC in an Ar atomsphere. Then the small test tube was coated with aluminum 
foil and stirred at 0 oC for half an hour. Later, this reaction mixture was shaken at RT 
overnight until the LC-ESI-MS indicated the complete conversion of the starting material to 
the product. The reaction mixture was mixed with DCM/MeCN and the DCU precipitate was 
removed by centrifugation. Finally purification via PrepHPLC (MeCN/H2O) afforded a violet 
crystal as the product 69.  
LC-ESIMS (MeCN/H2O)) of Monosulfone-OH Rhodamine B Ester 
a. HPLC spectrum 
















b. ESI-MS (+): C48H50N3O7S+ calcd. 812, found 812 
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Chapter 4. CONCLUSIONS 
 
In conclusion, one biology and two chemistry approaches toward site-directed protein 
modifications were developed. In conjunction with these protein modification strategies, three 
novel reactive rhodamine B dyes were prepared for straight forward modification of proteins 
and peptides.  
 
The biology means, termed selected pressure incorporation (SPI) is considered a novel and 
practical approach towards site-directed protein functionalization. Two major steps were 
involved. The first step was based on the preparation of the unnatural amino acid analogue, 
called NCAA such as AHA. This stage involved chemistry efforts since a new NCAA needs 
to be rationally designed and synthesized since the molecular structure of the NCAA 
represents a vital factor determining its translational activity (whether it can be recognized by 
the cell’s translational machinery) and whether it can be synthesized relatively easily. The 
second step is the incorporation of a NCAA into a protein sequence which requires the 
selection of an auxotrophic bacteria strain (bacteria which is unable to self-generate certain 
amino acids and must uptake them from environment in order to survive) and expression of 
the corresponding protein.  
 
In this thesis, AHA, a surrogate of methionine was successfully prepared and incorporated 
into RNase A to yield bis-azido RNase A modified in a site-directed fashion. AHA was 
prepared with a reliably enhanced yield compared to recently reported protocols. The average 
yield of this compound was 77 % which is higher than the published protocol with variable 
yields between 34 % and 59 %.[14] Subsequently, this NCAA was successfully incorporated 
into RNase A whose methionine residues were all replaced by AHA. Two AHA were located 
on the protein surface, namely AHA 1 and AHA 41, as identified by nanoLC-HR(ESI)MS/MS. 
Compared to another biological means—nonsense codon suppression—this biological 
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approach is less time consuming as it does not require the preparation of a new transfer-RNA: 
aminoacyl-tRNA-synthetase pair. This approach could be valuable to produce a variety of 
other azido-functionalized proteins and apply these protein variants to achieve 
activity-controlled bio-macromolecules or other protein level machineries.  
 
Two chemistry methods toward site-directed protein modifications were developed which 
allow fast and straight forward production of reasonable protein quantities compared with the 
SPI method and therefore, these approaches could be considered attractive alternatives. The 
first chemistry method targets a cysteine residue. Proteins that possess a single accessible 
cysteine residue on their surface were modified, such as serum albumin proteins, some 
antibody monomers etc. In this thesis, the bioconjugation 
reagent—biotin-PEG-maleimide—was developed and was successfully applied to achieve 
mono-biotinylated HSA via this cysteine-targeting approach. Since HSA bears a single 
cysteine residue at its surface and is considered suitable for this labeling strategy. However, 
not all proteins display an unpaired cysteine and therefore this approach still suffers from 
some inherent limitations.  
 
A more attractive chemistry method developed in this thesis focuses on the modification of 
lysine residues which in principle displays a broader application scope than targeting 
cysteines since lysine is typically located at the protein surface. Based on the 3-dimentional 
structure of proteins, the solvent accessibility of each lysine residue is calculated via MOE 
and the results suggest that the most accessible lysine can be addressed in a site-directed 
manner. The interaction of lysine with other residues in close vicinity via e.g. H-H bonding is 
also expected to affect the site-directionality. The bioconjugation reagent—biotin-PEG-NHS 
(49)—was developed for this application featuring a biotin moiety as an affinity purification 
tag, a PEG linker which contributes to water-solubility and an amine-reactive NHS ester 
group. This reagent was successfully applied to yield mono-biotinylated RNase A, lysozyme 
C and SST as demonstrated by a MALDI-ToF-MS study.  
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Four major steps are involved in this lysine-targeting approach. First, biotin-PEG-NHS is 
applied to the protein/peptide solution as the limiting reagent in a portion-wise fashion which 
is called the bioconjugation step. Thus, mono-modified protein is generated but still 
containing the native protein as well. Second, this protein solution is treated with a quenching 
reagent to deactivate the unreacted conjugation reagent—the quench step. The remaining 
biotin-containing small molecules which interfere with affinity chromatography are facilely 
removed via subsequently gel filtration. In the third step, the mono-biotinylated protein is 
separated from the protein mixture using monomeric Avidin resin and the unreacted native 
protein is recovered as well—the affinity chromatography step. In the last step, the affinity 
purified protein solution is subjected to a second gel filtration in order to remove biotin 
molecules and salts which originate from affinity chromatography eluent—the gel filtration 
step. We believe that this approach has broad applicability toward achieving mono-modified 
proteins and we also envision that a variety of bioorthogonal groups can be introduced onto 
protein surfaces via this approach thus enabling further click reactions. 
 
Finally, reactive rhodamine B dyes were prepared via one-step Steglich esterification and they 
were applied to decorate corresponding functionalized proteins/peptide. Three attractive 
rhodamine B derivatives were prepared including rhodamine B propargyl ester for labeling 
azido-proteins, rhodamine B azidoethyl ester for targeting ethynyl-proteins and 
monosulfone-OH rhodamine B ester as a disulfide-reactive chromophore. Their applicability 
for labeling corresponding type of proteins/peptide was demonstrated by experiments as well. 
Our efforts provide a new approach to prepare novel reactive rhodamine B as useful 





Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 75 
PUBLICATIONS 
The work presented in this master thesis has been incorporated in the following published or 
submitted journal articles:  
 
[1] X. Chen, K. Muthoosamy, A. Pfisterer, B. Neumann and T. Weil. Exploiting the intrinsic 
regioselectivity of lysine residues toward site-specific modification of native proteins and 
peptide: native chemical incorporation. J. Am. Chem. Soc. 2011 (submitted).  
[2] X. Chen, Q Wu, L. Henschke, T. Weil. One-step practical synthesis of useful rhodamine probes 
with an ester bond linkage. Dyes Pigments 2011 (submitted).  
[3] A. Pfisterer, K. Eisele, X. Chen, M. Wagner, K. Müllen and T. Weil. Bioactive unnatural 
somatostatin analogues through bioorthogonal iodo and ethynyl-disulfide intercalators. Chem. 
Eur. J. 2011 (online) 
[4] M. Lillich, X. Chen, T. Weil. H. Barth and J. Fahrer. Streptavidin-conjugated C3 protein 
mediates the delivery of mono-biotinylated RNase A into macrophases. J. Control. Release 











Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 76 
BIBLIOGRAPHY  
[1] G U Nienhaus, J Wiedenmann. Structure, dynamics and optical properties of fluorescent 
proteins: perspectives for marker development. ChemPhysChem 2009 (10) 1369 
[2] C Bosisio, V Quercioli, M Collini, L D’Alfonso, G Baldini, S Bettati, B Campanini, S 
Raboni, G Chirico. J. Phys. Chem. B 2008 (112) 8806 
[3]A E Miller, A J Fischer, T Laurence, C W Hollars, R J Saykally, J C Lagarias, T Huser. 
Single-molecule dynamics of phytochrome-bound fluorophores probed by fluorescence 
correlation spectroscopy. P. Natl. Acad. Sci. USA 2006 (103) 11136 
[4] M Eisenhawer, S Cattarinussi, A Kuhn, H Vogel. Fluorescence resonance energy transfer 
shows a close helix-helix distance in the transmembrane M13 procoat protein. Biochemistry 
2001 (40) 12321 
[5] Y Ishii, T Yoshida, T Funatsu, T Wazawa, T Yanagida. Fluorescence resonance energy 
transfer between single fluorophores attached to a coiled-coil protein in aqueous solution. 
Chem. Phys. 1999 (247) 163 
[6] X Michalet, S Weiss, M Jaoger. Single-molecule fluorescence studies of protein folding 
and conformational dynamics. Chem. Rev. 2006 (106), 1785 
[7] M W Fried et al. PEGinterferon alfa-2a plus ribavirin for chronic hepatitis C virus 
infection. N. Engl. J. Med. 2002 (347) 975 
[8] S J Hadziyannis et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic 
hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 
2004 (346) 
[9] A H Talal et al. Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected 
sustained virological responders from nonresponders. Hepatology 2006 (43) 943 
[10] J M Harris and R B Chess, Effect of PEGylation on pharmaceuticals. Nat. Rev. Drug. 
Discov. 2003 (2) 214 
[11] D R Corey and P G Schultz. Generation of a hybrid sequence-specific single-stranded 
deoxyribonuclease. Science 1986 (238) 1401  
Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 77 
[12] V W. Cornish, K M Hahn and P G Schultz. Site-specific protein modification using a 
ketone handle. J. Am. Chem. Soc. 1996 (118) 8150 
[13] S Schoffelen, M H L Lambermon, M B van Eldijk, J C M van Hest, Site-specific 
modification of Candida antarctica8b lipase B via residue-specific incorporation of a 
non-canonical amino acid, Bioconjugate Chem. 2008 (19) 1127 
[14] A J Link, M K S Vink, D A Tirrell, Preparation of the functionalizable methionine 
surrogate azidohomoalanine via copper-catalyzed diazo transfer. Nat. Protoc. 2007 (2)1879 
[15] A J Link, M K S Vink, D A Tirrell. Synthesis of the functionalizable methione surrogate 
azidohomoalanine using Boc-homoserine as precursor. Nat. Protoc. 2007 (2) 1884 
[16] E D Goddard-Borger and R B Stick. An Efficient, inexpensive, and shelf-stable 
diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride. Org. Lett. 2007 (9) 3797 
[17] K Bernd, A Janina, B Wolfgang. Alkyne bridged-amino acids by palladium mediated 
coupling of alkynes with N-t-Boc-4-iodo-phenylalanine methyl ester. Tetrahedron 1997 (53) 
2475 
[18] V W Cornish, D R Benson, C A Altenbach, K Hideg, W L Hubbell, P G Schultz. 
Site-specific incorporation of biophysical probes into proteins. P. Natl. Acad. Sci. USA 1994 
(91) 2910 
[19] L Wang, A Brock, B Herberich, P G Schultz. Expanding the genetic codon of Escherichia 
coli. Science 2001 (292) 498 
[20] J W. Chin, T A Croop, J C Anderson, M Mukherji, Z Zhang, P G Schultz. An expanded 
eukaryotic genetic code. Science 2003 (301) 964 
[21] L Wang, P G Schultz, Expanding the genetic code. Angew. Chem. Int. Ed. 2005 (44) 34 
[22] J M Xie, P G Schultz. A chemical toolkit for proteins—an expanded genetic code. Nat. 
Rev.: Mol. Cell Bio. 2006 (7) 775 
[23] K L Kiick, J C M van Hest and DA Tirrell. Expanding the scope of protein biosynthesis 
by altering the methionyl-tRNA synthetase activity of a bacterial expression host. Angew. 
Chem. Int. Ed. 2000 (39) 2148 
[24] J C M van Hest, K L Kiick, D A Tirrell. Efficient incorporation of unsaturated 
Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 78 
methionine analogues into proteins in vivo. J. Am. Chem. Soc. 2000 (122) 1282 
[25] K L Kiick, E Saxon, D A Tirrell, CR Bertozzi, Incorporation of azides into recombinant 
proteins for chemoselective modification by the Staudinger ligation. P. Natl. Acad. Sci. USA 
2002 (99)19 
[26] C Tanrikulu, E Schmitt, Y Mechulam, W A Goddard III, D A Tirrell. Discovery of 
Escherichia coli methionyl-tRNA synthetase mutants for efficient labeling of proteins with 
azidonorleucine in vivo. P. Natl. Acad. Sci. USA 2009 (106) 15285 
[27] K Kirshenbaum, I S Carrico and D A Tirrell. Biosynthesis of proteins incorporating a 
versatile set of phenylalanine analogues. ChemBioChem 2002 No. 02-03 235 
[28] J Wilhelmi, X Chen, et al. Unpublished data 2009 
[29] J M Antos and M B Francis. Selective Tryptophan Modification with rhodium 
carbenoids in aqueous solution. J. Am. Chem. Soc. 2004 (126) 10256. 
[30] S D Tilley and M B Francis. Tyrosine-selective protein alkylation using !-allylpalladium 
complexes. J. Am. Chem. Soc. 2006 (128) 1080 
[31] S Brocchini, S Balan, A Godwin, J W Choi, M Zloh and S Shaunak. PEGylation of 
native disulfide bonds in proteins. Nat. Protoc. 2006 (1) 2241 
[32] M Zloh, S Shaunak, S Balan and S Brocchini. Identification and insertion of 3-carbon 
bridges in protein disulfide bonds: a computational approach. Nat. Protoc. 2007 (2) 1070 
[33] J M Gilmore, R A Scheck, A P Esser-Kahn, N S Joshi and M B Francis, N-Terminal 
protein modification through a biomimeric transamination reactiono. Angew. Chem. Int. Ed. 
2006 (45) 5307 
[34] S N P Murthy, T J Lukas, T S Jardetzky and L Lorand. Selectivity in the 
post-translational, transglutaminase-dependent acylation of lysine residues. Biochemistry 
2009 (48) 2654. 
[35] T Nguyen and M B Francis. Practical synthetic route to functionalized rhodamine dyes, 
Org. Lett. 2003 (5) 3245 
[36] Q H Meng, M J Yu, H F Zhang, J C Ren and D Y Huang. Synthesis and application of 
N-hydroxysuccinimidyl rhodamine B ester as an amine-reactive fluorescent probe. Dyes 
Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 79 
Pigments 2007 (73) 254 
[37] J Futami, E Nukui, T Maeda, M Kosaka, H Tada, M Seno, H Yamada. Optimum 
modifcation for the highest cyttoxicity of cationized ribonuclease. J. Biochem. 2002 (132) 223 
[38] J Futami, T Maeda, M Kitazoe, E Nukui, H Tada, M Seno, M Kosaka, H Yamada. 
Preparation of potent cytotoxic ribonucleases by cationization: enhanced cellular uptake and 
decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl 
groups. Biochemistry 2001 (40) 7518 
[39] N Koval’ov, I Kuzenetsova, E Burakova, V Sil’nikov, M Zenkova, V Vlassov. 
International conference on targeting RNA/Workshop on biology and biochemistry of 
extracellular nucleic acids. JUN 18-21, 2003 Novosibirsk, RUSSIA, Nucleos. Nucleot. 
Nucleic Acids 2004 (23) 977 
[40] M Clarisse, P Hartmann, J P Obrecht. Titanium-mediated addition of silyl dienol ethers 
to electrophilic glycine: 4-ketopipecolic acid hydrochloride. Org. Synth. 1993 (71) 200 (1998, 
Coll. Vol9, p.527) 
[41] T Sasaki, K Kodama, H Suzuki, S Fukuzawa, K Tachibana, N-terminal labeling of 
proteins by the Pictet-Spengler reaction. Bioorg. Med. Chem. Lett. 2008 (18) 4550 
[42]M Zwolinska, P Smolewski, Onconase: a ribonuclease with antitumor activity. Postepy 
Hig. Med. Dosw. 2010 (64) 58 
[43] A Kbeck, H I Pass, M Carbone, H Yang, Ranpirnase as a potential antitumor ribonuclease 
treatment for mesothelioma and other malignancies. Future Onoco. 2008 (4) 341 
[44] L Strong, B Mei, J Kink, M Shaha, R Raines. Anti-cancer activity of human ribonuclease 
conjugates with enhanced pharmacokinetic profiles. EJC Supplements 2008 (6) 110 
[45] S L Dong, L Merkel, L Moroder, N Budisa. Convenient syntheses of 
homopropargylglycine. J Pept. Sci. 2008 (14) 1148 
[46] M Otagiri and V T G Chuang. Pharmaceutically Important Pre- and Posttranslational 
Modifications on Human Serum Albumin. Biol. Pharm. Bull. 2009 (32) 527 
 
Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 80 
APPENDICES 































































































































































































































































































































































Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 81 




















































































































































































































































Site-Directed Protein Modifications and Synthesis of Novel Rhodamine Chromophores (2010) Chen Xi 
 82 
5. 1H-1H COSY (MeOD) of Biotin-PEG-NHS 49 
 
6. 1H-NMR (CDCl3) of Pseudo Rhodamine B Propargyl Amide 57  
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15. 13C-NMR (CDCl3) of Monosulfone-OH 67 
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